Quiver News
The latest insights and financial news from Quiver Quantitative
$480,000 of NATIONAL FUEL GAS COMPANY lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"LIHEAP, pipeline permitting reform, climate change policy, pipeline safety reauthorization, energy policy (including renewable natural gas and hydrogen), natural gas appliances , federal oversight of natural gas use, Energy Star program, pipeline security & cybersecurity, natural gas use in federal facilities -- U.S. House of Representatives, U.S. Senate"
You can find more data on corporate lobbying on Quiver Quantitative.
NFG Hedge Fund Activity
We have seen 282 institutional investors add shares of NFG stock to their portfolio, and 246 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- THOMPSON SIEGEL & WALMSLEY LLC removed 720,855 shares (-70.7%) from their portfolio in Q1 2025, for an estimated $57,084,507
- VICTORY CAPITAL MANAGEMENT INC removed 581,143 shares (-22.5%) from their portfolio in Q1 2025, for an estimated $46,020,714
- GEODE CAPITAL MANAGEMENT, LLC removed 510,802 shares (-23.2%) from their portfolio in Q1 2025, for an estimated $40,450,410
- LSV ASSET MANAGEMENT added 491,890 shares (+29.6%) to their portfolio in Q1 2025, for an estimated $38,952,769
- INVESCO LTD. added 460,100 shares (+93.7%) to their portfolio in Q1 2025, for an estimated $36,435,319
- VANGUARD GROUP INC removed 427,159 shares (-3.3%) from their portfolio in Q1 2025, for an estimated $33,826,721
- MACKENZIE FINANCIAL CORP added 355,800 shares (+98.9%) to their portfolio in Q1 2025, for an estimated $28,175,802
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NFG Analyst Ratings
Wall Street analysts have issued reports on $NFG in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 07/15/2025
- Scotiabank issued a "Sector Outperform" rating on 07/11/2025
To track analyst ratings and price targets for NFG, check out Quiver Quantitative's $NFG forecast page.
NFG Price Targets
Multiple analysts have issued price targets for $NFG recently. We have seen 5 analysts offer price targets for $NFG in the last 6 months, with a median target of $85.0.
Here are some recent targets:
- Noah Hungness from B of A Securities set a target price of $107.0 on 07/15/2025
- Cameron Bean from Scotiabank set a target price of $98.0 on 07/11/2025
- Zach Parham from JP Morgan set a target price of $81.0 on 03/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of NMI HOLDINGS INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"*No specific bill number/all matters relating to housing and PMI Insurance"
You can find more data on corporate lobbying on Quiver Quantitative.
NMIH Insider Trading Activity
NMIH insiders have traded $NMIH stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $NMIH stock by insiders over the last 6 months:
- ADAM POLLITZER (Chief Executive Officer) sold 57,166 shares for an estimated $2,089,051
- WILLIAM J LEATHERBERRY (Chief Admin. Officer & GC) has made 0 purchases and 3 sales selling 42,121 shares for an estimated $1,584,040.
- BRADLEY M SHUSTER (Executive Chairman) sold 21,545 shares for an estimated $852,283
- ROBERT OWEN SMITH (EVP, Chief Risk Officer) sold 20,000 shares for an estimated $731,581
- NORMAN PETER FITZGERALD (EVP, Chief Sales Officer) sold 20,000 shares for an estimated $717,600
- MOHAMMAD NAWAZ YOUSAF (EVP, Chief of Ops and Tech) has made 0 purchases and 2 sales selling 16,600 shares for an estimated $591,717.
- NICHOLAS DANIEL REALMUTO (VP, Controller) has made 0 purchases and 5 sales selling 5,599 shares for an estimated $97,334.
- MICHAEL CURRY MONTGOMERY sold 1,875 shares for an estimated $71,344
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NMIH Hedge Fund Activity
We have seen 168 institutional investors add shares of NMIH stock to their portfolio, and 156 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,174,358 shares (-81.3%) from their portfolio in Q1 2025, for an estimated $42,335,605
- ASSENAGON ASSET MANAGEMENT S.A. removed 1,002,191 shares (-49.3%) from their portfolio in Q2 2025, for an estimated $42,282,438
- MILLENNIUM MANAGEMENT LLC added 970,551 shares (+209.9%) to their portfolio in Q1 2025, for an estimated $34,988,363
- BLACKROCK, INC. removed 605,089 shares (-4.4%) from their portfolio in Q1 2025, for an estimated $21,813,458
- GOLDENTREE ASSET MANAGEMENT LP added 512,527 shares (+61.5%) to their portfolio in Q1 2025, for an estimated $18,476,598
- DONALD SMITH & CO., INC. removed 459,234 shares (-35.1%) from their portfolio in Q1 2025, for an estimated $16,555,385
- INVESCO LTD. removed 362,652 shares (-38.8%) from their portfolio in Q1 2025, for an estimated $13,073,604
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NMIH Analyst Ratings
Wall Street analysts have issued reports on $NMIH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 07/11/2025
- Compass Point issued a "Buy" rating on 05/23/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 04/08/2025
To track analyst ratings and price targets for NMIH, check out Quiver Quantitative's $NMIH forecast page.
NMIH Price Targets
Multiple analysts have issued price targets for $NMIH recently. We have seen 5 analysts offer price targets for $NMIH in the last 6 months, with a median target of $42.0.
Here are some recent targets:
- Richard Shane from JP Morgan set a target price of $44.0 on 07/11/2025
- Terry Ma from Barclays set a target price of $42.0 on 07/08/2025
- Bose George from Keefe, Bruyette & Woods set a target price of $43.0 on 07/07/2025
- Chris Gamaitoni from Compass Point set a target price of $37.0 on 05/23/2025
- Doug Harter from UBS set a target price of $41.0 on 02/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$150,000 of CORMEDIX INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R.____/S.____, Chronic Kidney Disease Improvement in Research and Treatment Act Issues related to patient access to infection prevention."
You can find more data on corporate lobbying on Quiver Quantitative.
CRMD Hedge Fund Activity
We have seen 77 institutional investors add shares of CRMD stock to their portfolio, and 51 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST TURN MANAGEMENT, LLC removed 1,021,421 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $6,291,953
- OBERWEIS ASSET MANAGEMENT INC/ added 485,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,987,600
- J. GOLDMAN & CO LP removed 457,320 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,817,091
- ELLIOTT INVESTMENT MANAGEMENT L.P. removed 426,071 shares (-14.8%) from their portfolio in Q1 2025, for an estimated $2,624,597
- MORGAN STANLEY added 304,891 shares (+76.4%) to their portfolio in Q1 2025, for an estimated $1,878,128
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 295,623 shares (+1106.1%) to their portfolio in Q1 2025, for an estimated $1,821,037
- VANGUARD GROUP INC added 268,360 shares (+7.9%) to their portfolio in Q1 2025, for an estimated $1,653,097
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CRMD Analyst Ratings
Wall Street analysts have issued reports on $CRMD in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 06/30/2025
- Needham issued a "Buy" rating on 06/24/2025
- RBC Capital issued a "Outperform" rating on 06/20/2025
- Leerink Partners issued a "Outperform" rating on 03/07/2025
To track analyst ratings and price targets for CRMD, check out Quiver Quantitative's $CRMD forecast page.
CRMD Price Targets
Multiple analysts have issued price targets for $CRMD recently. We have seen 6 analysts offer price targets for $CRMD in the last 6 months, with a median target of $17.5.
Here are some recent targets:
- Brandon Folkes from HC Wainwright & Co. set a target price of $20.0 on 06/30/2025
- Serge Belanger from Needham set a target price of $20.0 on 06/24/2025
- Jason Kolbert from D. Boral Capital set a target price of $15.0 on 06/23/2025
- Leonid Timashev from RBC Capital set a target price of $17.0 on 06/20/2025
- Roanna Ruiz from Leerink Partners set a target price of $18.0 on 03/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of VAXART INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Vaccine policy."
You can find more data on corporate lobbying on Quiver Quantitative.
VXRT Insider Trading Activity
VXRT insiders have traded $VXRT stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $VXRT stock by insiders over the last 6 months:
- STEVEN LO (President, Chief Exec Officer) purchased 100,000 shares for an estimated $49,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
VXRT Hedge Fund Activity
We have seen 26 institutional investors add shares of VXRT stock to their portfolio, and 35 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIO CAPITAL MANAGEMENT, LLC removed 5,931,867 shares (-51.5%) from their portfolio in Q1 2025, for an estimated $2,414,269
- MILLENNIUM MANAGEMENT LLC removed 2,034,776 shares (-68.0%) from their portfolio in Q1 2025, for an estimated $828,153
- CITADEL ADVISORS LLC removed 501,623 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $204,160
- JONES FINANCIAL COMPANIES LLLP added 478,111 shares (+276364.7%) to their portfolio in Q1 2025, for an estimated $194,591
- SILVERARC CAPITAL MANAGEMENT, LLC removed 393,957 shares (-36.6%) from their portfolio in Q1 2025, for an estimated $160,340
- VANGUARD GROUP INC added 291,506 shares (+2.9%) to their portfolio in Q1 2025, for an estimated $118,642
- SQUAREPOINT OPS LLC added 287,677 shares (+55.7%) to their portfolio in Q1 2025, for an estimated $117,084
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
VXRT Analyst Ratings
Wall Street analysts have issued reports on $VXRT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B. Riley Securities issued a "Buy" rating on 03/27/2025
To track analyst ratings and price targets for VXRT, check out Quiver Quantitative's $VXRT forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$200,000 of WOODSIDE ENERGY GROUP LTD lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Discussed international trade policy impact on building a domestic LNG project and on US LNG exports to foreign nations. Update on Woodside Energy's LNG export facility, Louisiana LNG, and progress being made towards project completion. Issues related to offshore oil & gas lease sales and regulations. Discussed tariffs impact on materials needed to build a domestic LNG project and on US LNG exports to foreign nations."
You can find more data on corporate lobbying on Quiver Quantitative.
WDS Hedge Fund Activity
We have seen 114 institutional investors add shares of WDS stock to their portfolio, and 129 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,426,683 shares (-77.6%) from their portfolio in Q1 2025, for an estimated $20,672,636
- POINT72 ASSET MANAGEMENT, L.P. added 729,400 shares (+inf%) to their portfolio in Q1 2025, for an estimated $10,569,006
- GOLDMAN SACHS GROUP INC removed 597,212 shares (-19.9%) from their portfolio in Q1 2025, for an estimated $8,653,601
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 519,231 shares (+150.3%) to their portfolio in Q1 2025, for an estimated $7,523,657
- MARSHALL WACE, LLP removed 477,935 shares (-95.5%) from their portfolio in Q1 2025, for an estimated $6,925,278
- ASSOCIATED BANC-CORP removed 429,768 shares (-72.2%) from their portfolio in Q1 2025, for an estimated $6,227,338
- UBS GROUP AG removed 370,166 shares (-78.4%) from their portfolio in Q1 2025, for an estimated $5,363,705
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$10,000 of DIEBOLD NIXDORF lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R.1138 - Payment Choice Act of 2025 This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less, and it prohibits them from charging cash- paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill provides for enforcement through preventative relief, damages, and civil penalties. H.R.1138 - Payment Choice Act of 2025 This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less, and it prohibits them from charging cash- paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill provides for enforcement through preventative relief, damages, and civil penalties. H.R.1138 - Payment Choice Act of 2025 This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less, and it prohibits them from charging cash- paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill provides for enforcement through preventative relief, damages, and civil penalties."
You can find more data on corporate lobbying on Quiver Quantitative.
DBD Insider Trading Activity
DBD insiders have traded $DBD stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $DBD stock by insiders over the last 6 months:
- WORLD INVESTORS CAPITAL sold 19,842 shares for an estimated $866,103
- EMANUEL R PEARLMAN has made 0 purchases and 2 sales selling 2,000 shares for an estimated $87,360.
- FRANK TOBIAS BAUR (EVP of Operational Excellence) purchased 700 shares for an estimated $32,284
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DBD Hedge Fund Activity
We have seen 61 institutional investors add shares of DBD stock to their portfolio, and 65 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BEACH POINT CAPITAL MANAGEMENT LP removed 317,399 shares (-16.8%) from their portfolio in Q2 2025, for an estimated $17,583,904
- NEW VERNON CAPITAL HOLDINGS II LLC added 244,351 shares (+inf%) to their portfolio in Q1 2025, for an estimated $10,683,025
- GLENDON CAPITAL MANAGEMENT LP added 180,232 shares (+13.7%) to their portfolio in Q1 2025, for an estimated $7,879,743
- UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH added 153,600 shares (+inf%) to their portfolio in Q1 2025, for an estimated $6,715,392
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 140,290 shares (+9.5%) to their portfolio in Q2 2025, for an estimated $7,772,066
- DIMENSIONAL FUND ADVISORS LP added 114,486 shares (+18.2%) to their portfolio in Q1 2025, for an estimated $5,005,327
- SKYLANDS CAPITAL, LLC added 103,975 shares (+23.3%) to their portfolio in Q1 2025, for an estimated $4,545,787
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DBD Analyst Ratings
Wall Street analysts have issued reports on $DBD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- DA Davidson issued a "Buy" rating on 02/27/2025
To track analyst ratings and price targets for DBD, check out Quiver Quantitative's $DBD forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$340,000 of KLA CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Research and development funding and tax benefits in support of the semiconductor industry. Trade policy regarding China, including tariffs and export controls on semiconductor manufacturing equipment for advanced models."
You can find more data on corporate lobbying on Quiver Quantitative.
KLAC Insider Trading Activity
KLAC insiders have traded $KLAC stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $KLAC stock by insiders over the last 6 months:
- RICHARD P WALLACE (President and CEO) sold 10,802 shares for an estimated $7,381,006
- BREN D. HIGGINS (EVP & Chief Financial Officer) has made 0 purchases and 2 sales selling 8,027 shares for an estimated $5,859,159.
- VIRENDRA A KIRLOSKAR (SVP & Chief Accounting Officer) sold 39 shares for an estimated $34,768
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
KLAC Hedge Fund Activity
We have seen 751 institutional investors add shares of KLAC stock to their portfolio, and 724 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 1,671,582 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $1,497,302,860
- CAPITAL WORLD INVESTORS added 675,430 shares (+inf%) to their portfolio in Q1 2025, for an estimated $459,157,313
- GOLDMAN SACHS GROUP INC added 404,634 shares (+27.9%) to their portfolio in Q1 2025, for an estimated $275,070,193
- QUBE RESEARCH & TECHNOLOGIES LTD removed 383,182 shares (-87.6%) from their portfolio in Q1 2025, for an estimated $260,487,123
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 350,072 shares (-17.1%) from their portfolio in Q1 2025, for an estimated $237,978,945
- PROFICIO CAPITAL PARTNERS LLC removed 341,905 shares (-99.8%) from their portfolio in Q1 2025, for an estimated $232,427,018
- PRIMECAP MANAGEMENT CO/CA/ removed 307,560 shares (-5.9%) from their portfolio in Q1 2025, for an estimated $209,079,288
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KLAC Analyst Ratings
Wall Street analysts have issued reports on $KLAC in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 07/01/2025
- Oppenheimer issued a "Outperform" rating on 06/17/2025
- Needham issued a "Buy" rating on 05/01/2025
- Stifel issued a "Buy" rating on 05/01/2025
- JP Morgan issued a "Overweight" rating on 05/01/2025
- B of A Securities issued a "Buy" rating on 04/16/2025
- Citigroup issued a "Buy" rating on 04/11/2025
To track analyst ratings and price targets for KLAC, check out Quiver Quantitative's $KLAC forecast page.
KLAC Price Targets
Multiple analysts have issued price targets for $KLAC recently. We have seen 15 analysts offer price targets for $KLAC in the last 6 months, with a median target of $900.0.
Here are some recent targets:
- Tom O'Malley from Barclays set a target price of $750.0 on 07/28/2025
- Timothy Arcuri from UBS set a target price of $960.0 on 07/21/2025
- James Schneider from Goldman Sachs set a target price of $980.0 on 07/10/2025
- Joseph Quatrochi from Wells Fargo set a target price of $920.0 on 07/08/2025
- Atif Malik from Citigroup set a target price of $1035.0 on 07/07/2025
- Shane Brett from Morgan Stanley set a target price of $916.0 on 07/01/2025
- Matthew Prisco from Cantor Fitzgerald set a target price of $950.0 on 06/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$545,708 of INTERDIGITAL INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Pro-IP legislation including RESTORE, PREVAIL and PERA including other general patent and IP issues as well as IP issues related to China Matters related to the ITC, other IP issues and IP matters related to China and other trade agreements or matters concerning IP and Trade Wireless communications, 5G, 6G, IoT, ORAN, spectrum matters, streaming services and other broadband, wireless and video standards issues Corporate tax issues and other tax matters affecting publicly traded companies"
You can find more data on corporate lobbying on Quiver Quantitative.
IDCC Insider Trading Activity
IDCC insiders have traded $IDCC stock on the open market 94 times in the past 6 months. Of those trades, 0 have been purchases and 94 have been sales.
Here’s a breakdown of recent trading of $IDCC stock by insiders over the last 6 months:
- LAWRENCE LIREN CHEN (President and CEO) has made 0 purchases and 39 sales selling 100,000 shares for an estimated $20,832,391.
- RICHARD BREZSKI (Chief Financial Officer) has made 0 purchases and 14 sales selling 31,530 shares for an estimated $6,757,299.
- STEWART D HUTCHESON has made 0 purchases and 8 sales selling 8,398 shares for an estimated $1,797,393.
- EEVA K. HAKORANTA (Chief Licensing Officer) has made 0 purchases and 4 sales selling 5,150 shares for an estimated $1,121,107.
- RAJESH PANKAJ (Chief Technology Officer) has made 0 purchases and 5 sales selling 3,800 shares for an estimated $779,666.
- JEAN F RANKIN has made 0 purchases and 9 sales selling 3,285 shares for an estimated $734,622.
- JOSHUA D. SCHMIDT (CLO & Corp Secretary) has made 0 purchases and 4 sales selling 2,247 shares for an estimated $496,528.
- JOHN D. JR. MARKLEY has made 0 purchases and 2 sales selling 1,384 shares for an estimated $306,293.
- SAMIR ARMALY has made 0 purchases and 3 sales selling 779 shares for an estimated $176,456.
- DEREK K ABERLE has made 0 purchases and 3 sales selling 692 shares for an estimated $156,676.
- JOHN A KRITZMACHER has made 0 purchases and 3 sales selling 519 shares for an estimated $117,632.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
IDCC Hedge Fund Activity
We have seen 260 institutional investors add shares of IDCC stock to their portfolio, and 206 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST TRUST ADVISORS LP added 432,691 shares (+418.9%) to their portfolio in Q1 2025, for an estimated $89,458,864
- BOSTON PARTNERS removed 405,070 shares (-25.0%) from their portfolio in Q1 2025, for an estimated $83,748,222
- GAMMA INVESTING LLC removed 297,892 shares (-99.4%) from their portfolio in Q2 2025, for an estimated $66,796,323
- NEW VERNON CAPITAL HOLDINGS II LLC added 204,081 shares (+25257.5%) to their portfolio in Q1 2025, for an estimated $42,193,746
- FMR LLC added 174,982 shares (+3800.7%) to their portfolio in Q1 2025, for an estimated $36,177,528
- SHANNON RIVER FUND MANAGEMENT LLC removed 156,643 shares (-41.0%) from their portfolio in Q1 2025, for an estimated $32,385,940
- AMERICAN CENTURY COMPANIES INC removed 156,327 shares (-36.8%) from their portfolio in Q1 2025, for an estimated $32,320,607
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$10,000 of BRIGHTSPRING HEALTH SERVICES lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Long-term care pharmacy fix, Medicaid in reconciliation, Medicare payment rules including home health and physician fee schedule, home infusion fix Long-term care pharmacy fix, IRA implementation"
You can find more data on corporate lobbying on Quiver Quantitative.
BTSG Insider Trading Activity
BTSG insiders have traded $BTSG stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $BTSG stock by insiders over the last 6 months:
- GROUP PARTNERSHIP L.P. KKR has made 0 purchases and 2 sales selling 15,388,101 shares for an estimated $325,487,573.
- PHOENIX AGGREGATOR L.P. KKR has made 0 purchases and 2 sales selling 15,388,101 shares for an estimated $325,487,573.
- BOOTS ALLIANCE, INC. WALGREENS sold 12,000,000 shares for an estimated $253,920,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BTSG Hedge Fund Activity
We have seen 96 institutional investors add shares of BTSG stock to their portfolio, and 67 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WALGREENS BOOTS ALLIANCE, INC. removed 12,000,000 shares (-51.6%) from their portfolio in Q1 2025, for an estimated $217,080,000
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 4,189,805 shares (+264.7%) to their portfolio in Q1 2025, for an estimated $75,793,572
- FMR LLC added 4,010,819 shares (+18.1%) to their portfolio in Q1 2025, for an estimated $72,555,715
- 8 KNOTS MANAGEMENT, LLC removed 3,172,788 shares (-68.3%) from their portfolio in Q1 2025, for an estimated $57,395,734
- POINT72 ASSET MANAGEMENT, L.P. added 2,544,232 shares (+inf%) to their portfolio in Q1 2025, for an estimated $46,025,156
- INVESCO LTD. added 1,794,035 shares (+41.0%) to their portfolio in Q1 2025, for an estimated $32,454,093
- VANGUARD GROUP INC added 1,308,651 shares (+24.6%) to their portfolio in Q1 2025, for an estimated $23,673,496
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BTSG Analyst Ratings
Wall Street analysts have issued reports on $BTSG in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 05/13/2025
- Morgan Stanley issued a "Overweight" rating on 05/09/2025
To track analyst ratings and price targets for BTSG, check out Quiver Quantitative's $BTSG forecast page.
BTSG Price Targets
Multiple analysts have issued price targets for $BTSG recently. We have seen 2 analysts offer price targets for $BTSG in the last 6 months, with a median target of $26.0.
Here are some recent targets:
- Stephen Baxter from Wells Fargo set a target price of $27.0 on 05/13/2025
- Erin Wright from Morgan Stanley set a target price of $25.0 on 05/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$180,000 of SHOPIFY INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to the reform of laws relating to the protection of intellectual property rights. Issues related to competition in the market for credit card routing, including support for The Credit Card Competition Act. Issues related to the growth of independent small businesses in the digital economy. Issues related to online government resources for small businesses, including support for the One Stop Shop for Small Business Licensing Act. Issues related to modernizing small business grants and mentoring to promote a greater focus on e-commerce. Issues related to combating online sale of counterfeit goods. Issues related to consumer privacy. Issues related to Self-Employment Assistance programs and removing barriers to entrepreneurship in unemployment insurance, including support for The NO BOSS Act. Issues related to accessibility standards for website design. Issues related to artificial intelligence and its benefits for small business. Issues related to the regulation of financial technology. Issues related to small business and corporate tax reform, including support for H.R. 703 / S. 213, the Main Street Tax Certainty Act, and H.R. 1, One Big Beautiful Bill Act. Issues related to the impact of tariffs and changes to the de minimis exemption on small businesses."
You can find more data on corporate lobbying on Quiver Quantitative.
SHOP Congressional Stock Trading
Members of Congress have traded $SHOP stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $SHOP stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/03.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 3 times. They made 2 purchases worth up to $30,000 on 02/12, 02/03 and 1 sale worth up to $15,000 on 03/19.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
SHOP Hedge Fund Activity
We have seen 706 institutional investors add shares of SHOP stock to their portfolio, and 686 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EDGEWOOD MANAGEMENT LLC added 8,646,159 shares (+inf%) to their portfolio in Q1 2025, for an estimated $825,535,261
- PRICE T ROWE ASSOCIATES INC /MD/ removed 7,892,382 shares (-18.8%) from their portfolio in Q1 2025, for an estimated $753,564,633
- FMR LLC added 5,507,642 shares (+12.6%) to their portfolio in Q1 2025, for an estimated $525,869,658
- JPMORGAN CHASE & CO added 4,597,678 shares (+19.6%) to their portfolio in Q1 2025, for an estimated $438,986,295
- GOLDMAN SACHS GROUP INC added 4,550,721 shares (+128.0%) to their portfolio in Q1 2025, for an estimated $434,502,841
- JENNISON ASSOCIATES LLC added 4,036,326 shares (+324.3%) to their portfolio in Q1 2025, for an estimated $385,388,406
- BAILLIE GIFFORD & CO removed 3,898,764 shares (-6.5%) from their portfolio in Q1 2025, for an estimated $372,253,986
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SHOP Analyst Ratings
Wall Street analysts have issued reports on $SHOP in the last several months. We have seen 16 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 07/28/2025
- CIBC issued a "Outperformer" rating on 07/18/2025
- Baird issued a "Outperform" rating on 07/14/2025
- Needham issued a "Buy" rating on 07/14/2025
- DA Davidson issued a "Buy" rating on 06/16/2025
- Wells Fargo issued a "Overweight" rating on 06/06/2025
- JP Morgan issued a "Overweight" rating on 05/09/2025
To track analyst ratings and price targets for SHOP, check out Quiver Quantitative's $SHOP forecast page.
SHOP Price Targets
Multiple analysts have issued price targets for $SHOP recently. We have seen 29 analysts offer price targets for $SHOP in the last 6 months, with a median target of $120.0.
Here are some recent targets:
- Ken Wong from Oppenheimer set a target price of $145.0 on 07/28/2025
- Justin Patterson from Keybanc set a target price of $145.0 on 07/22/2025
- Anthony Chukumba from Loop Capital set a target price of $120.0 on 07/22/2025
- Todd Coupland from CIBC set a target price of $145.0 on 07/18/2025
- Parker Lane from Stifel set a target price of $110.0 on 07/15/2025
- Scott Berg from Needham set a target price of $135.0 on 07/14/2025
- Colin Sebastian from Baird set a target price of $120.0 on 07/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$241,000 of GUARDANT HEALTH lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"precision diagnostics and preventive screening innovation precision diagnostics, cancer care, and preventive screening innovation"
You can find more data on corporate lobbying on Quiver Quantitative.
GH Insider Trading Activity
GH insiders have traded $GH stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $GH stock by insiders over the last 6 months:
- AMIRALI TALASAZ (Co-Chief Executive Officer) has made 0 purchases and 12 sales selling 340,000 shares for an estimated $16,998,565.
- KUMUD KALIA (Chief Information Officer) has made 0 purchases and 2 sales selling 7,500 shares for an estimated $336,621.
- IAN T CLARK sold 6,672 shares for an estimated $322,818
- MUSA TARIQ has made 0 purchases and 5 sales selling 3,677 shares for an estimated $179,984.
- MEGHAN V. JOYCE has made 0 purchases and 3 sales selling 3,537 shares for an estimated $166,010.
- MYRTLE S POTTER has made 0 purchases and 3 sales selling 2,678 shares for an estimated $133,051.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GH Hedge Fund Activity
We have seen 167 institutional investors add shares of GH stock to their portfolio, and 161 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 2,855,482 shares (-58.9%) from their portfolio in Q1 2025, for an estimated $121,643,533
- CITADEL ADVISORS LLC added 2,115,024 shares (+142.7%) to their portfolio in Q1 2025, for an estimated $90,100,022
- FIL LTD removed 1,943,061 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $82,774,398
- DRIEHAUS CAPITAL MANAGEMENT LLC added 1,933,086 shares (+inf%) to their portfolio in Q1 2025, for an estimated $82,349,463
- BRAIDWELL LP removed 1,520,604 shares (-53.4%) from their portfolio in Q1 2025, for an estimated $64,777,730
- INVESCO LTD. added 1,403,670 shares (+100.9%) to their portfolio in Q1 2025, for an estimated $59,796,342
- DEEP TRACK CAPITAL, LP removed 975,845 shares (-15.2%) from their portfolio in Q1 2025, for an estimated $41,570,997
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GH Analyst Ratings
Wall Street analysts have issued reports on $GH in the last several months. We have seen 14 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 06/13/2025
- Piper Sandler issued a "Overweight" rating on 05/06/2025
- Scotiabank issued a "Sector Outperform" rating on 05/05/2025
- Canaccord Genuity issued a "Buy" rating on 05/01/2025
- Stifel issued a "Buy" rating on 05/01/2025
- Barclays issued a "Overweight" rating on 05/01/2025
- TD Securities issued a "Buy" rating on 05/01/2025
To track analyst ratings and price targets for GH, check out Quiver Quantitative's $GH forecast page.
GH Price Targets
Multiple analysts have issued price targets for $GH recently. We have seen 14 analysts offer price targets for $GH in the last 6 months, with a median target of $59.5.
Here are some recent targets:
- Anthony Petrone from Mizuho set a target price of $65.0 on 06/13/2025
- David Westenberg from Piper Sandler set a target price of $60.0 on 05/06/2025
- Sung Ji Nam from Scotiabank set a target price of $57.0 on 05/05/2025
- Dan Brennan from TD Securities set a target price of $60.0 on 05/01/2025
- Daniel Arias from Stifel set a target price of $60.0 on 05/01/2025
- Kyle Mikson from Canaccord Genuity set a target price of $65.0 on 05/01/2025
- Luke Sergott from Barclays set a target price of $60.0 on 05/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$480,000 of EXACT SCIENCES lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Support legislative efforts to develop alternative diagnostics legislation in lieu of LDT rule. Support veteran access to guideline-recommended colorectal cancer screening. HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act: This bill allows, beginning in 2028, for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. Coverage is limited to those under a certain age (age 68 in 2028, increased by one year every year thereafter) and to one test every 11 months."
You can find more data on corporate lobbying on Quiver Quantitative.
EXAS Insider Trading Activity
EXAS insiders have traded $EXAS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EXAS stock by insiders over the last 6 months:
- KATHERINE S ZANOTTI sold 3,207 shares for an estimated $170,612
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EXAS Hedge Fund Activity
We have seen 242 institutional investors add shares of EXAS stock to their portfolio, and 294 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 6,970,041 shares (+33.6%) to their portfolio in Q1 2025, for an estimated $301,733,074
- JPMORGAN CHASE & CO removed 2,989,522 shares (-85.6%) from their portfolio in Q1 2025, for an estimated $129,416,407
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 2,009,503 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $86,991,384
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,707,287 shares (+120.1%) to their portfolio in Q1 2025, for an estimated $73,908,454
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,350,794 shares (-31.6%) from their portfolio in Q1 2025, for an estimated $58,475,872
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 1,195,473 shares (-34.7%) from their portfolio in Q1 2025, for an estimated $51,752,026
- MILLENNIUM MANAGEMENT LLC removed 886,022 shares (-37.5%) from their portfolio in Q1 2025, for an estimated $38,355,892
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EXAS Analyst Ratings
Wall Street analysts have issued reports on $EXAS in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 06/24/2025
- Evercore ISI Group issued a "Outperform" rating on 05/02/2025
- Baird issued a "Outperform" rating on 05/02/2025
- Guggenheim issued a "Buy" rating on 04/11/2025
- Mizuho issued a "Outperform" rating on 04/10/2025
- Piper Sandler issued a "Overweight" rating on 02/26/2025
- Scotiabank issued a "Sector Outperform" rating on 02/24/2025
To track analyst ratings and price targets for EXAS, check out Quiver Quantitative's $EXAS forecast page.
EXAS Price Targets
Multiple analysts have issued price targets for $EXAS recently. We have seen 9 analysts offer price targets for $EXAS in the last 6 months, with a median target of $65.0.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $68.0 on 07/08/2025
- Luke Sergott from Barclays set a target price of $65.0 on 06/24/2025
- Gerard Cassidy from RBC Capital set a target price of $54.0 on 05/02/2025
- Catherine Schulte from Baird set a target price of $72.0 on 05/02/2025
- Subbu Nambi from Guggenheim set a target price of $60.0 on 04/11/2025
- Anthony Petrone from Mizuho set a target price of $60.0 on 04/10/2025
- David Westenberg from Piper Sandler set a target price of $70.0 on 02/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of ONTO INNOVATION INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to trade, export controls and tariffs. Issues related to export controls"
You can find more data on corporate lobbying on Quiver Quantitative.
ONTO Congressional Stock Trading
Members of Congress have traded $ONTO stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ONTO stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 05/12, 05/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ONTO Insider Trading Activity
ONTO insiders have traded $ONTO stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ONTO stock by insiders over the last 6 months:
- SRINIVAS VEDULA (SVP, Customer Success) sold 238 shares for an estimated $40,360
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ONTO Hedge Fund Activity
We have seen 222 institutional investors add shares of ONTO stock to their portfolio, and 288 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 1,515,152 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $183,848,543
- SITUATIONAL AWARENESS LP added 586,717 shares (+inf%) to their portfolio in Q1 2025, for an estimated $71,192,240
- MACQUARIE GROUP LTD added 464,265 shares (+86.5%) to their portfolio in Q1 2025, for an estimated $56,333,915
- CONGRESS ASSET MANAGEMENT CO removed 448,660 shares (-99.1%) from their portfolio in Q2 2025, for an estimated $45,283,253
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 421,165 shares (+48.4%) to their portfolio in Q1 2025, for an estimated $51,104,161
- FRANKLIN RESOURCES INC removed 345,623 shares (-22.3%) from their portfolio in Q1 2025, for an estimated $41,937,894
- NEUBERGER BERMAN GROUP LLC removed 306,748 shares (-58.2%) from their portfolio in Q1 2025, for an estimated $37,220,802
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ONTO Analyst Ratings
Wall Street analysts have issued reports on $ONTO in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 05/09/2025
- Benchmark issued a "Buy" rating on 05/09/2025
- Needham issued a "Buy" rating on 05/09/2025
- Stifel issued a "Buy" rating on 04/15/2025
To track analyst ratings and price targets for ONTO, check out Quiver Quantitative's $ONTO forecast page.
ONTO Price Targets
Multiple analysts have issued price targets for $ONTO recently. We have seen 6 analysts offer price targets for $ONTO in the last 6 months, with a median target of $140.0.
Here are some recent targets:
- Matthew Prisco from Cantor Fitzgerald set a target price of $90.0 on 06/24/2025
- Blayne Curtis from Jefferies set a target price of $110.0 on 05/20/2025
- Edward Yang from Oppenheimer set a target price of $130.0 on 05/09/2025
- Mark Miller from Benchmark set a target price of $190.0 on 05/09/2025
- Charles Shi from Needham set a target price of $150.0 on 05/09/2025
- Brian Chin from Stifel set a target price of $180.0 on 04/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of MIMEDX lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"regulatory issues related to the delivery of wound management and skin substitutes for Medicare patients"
You can find more data on corporate lobbying on Quiver Quantitative.
MDXG Insider Trading Activity
MDXG insiders have traded $MDXG stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $MDXG stock by insiders over the last 6 months:
- JOSEPH H CAPPER (Chief Executive Officer) purchased 200,000 shares for an estimated $1,268,000
- WILLIAM FRANK IV HULSE (General Counsel and CAO) has made 0 purchases and 3 sales selling 136,042 shares for an estimated $1,066,041.
- RICCI S WHITLOW (Chief Operating Officer) sold 61,420 shares for an estimated $508,557
- KIMBERLY MAERSK-MOLLER (Chief Commercial Officer) has made 0 purchases and 3 sales selling 7,976 shares for an estimated $64,281.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MDXG Hedge Fund Activity
We have seen 94 institutional investors add shares of MDXG stock to their portfolio, and 90 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CANNELL CAPITAL LLC removed 1,506,585 shares (-41.4%) from their portfolio in Q1 2025, for an estimated $11,450,046
- MILLENNIUM MANAGEMENT LLC added 596,016 shares (+93.9%) to their portfolio in Q1 2025, for an estimated $4,529,721
- BLACKROCK, INC. added 582,644 shares (+6.1%) to their portfolio in Q1 2025, for an estimated $4,428,094
- MEROS INVESTMENT MANAGEMENT, LP added 425,531 shares (+107.7%) to their portfolio in Q1 2025, for an estimated $3,234,035
- PHOCAS FINANCIAL CORP. added 380,014 shares (+1193.8%) to their portfolio in Q1 2025, for an estimated $2,888,106
- D. E. SHAW & CO., INC. added 363,630 shares (+149.7%) to their portfolio in Q1 2025, for an estimated $2,763,588
- MARSHALL WACE, LLP removed 348,747 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,650,477
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MDXG Analyst Ratings
Wall Street analysts have issued reports on $MDXG in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 07/15/2025
To track analyst ratings and price targets for MDXG, check out Quiver Quantitative's $MDXG forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$730,000 of PRIMERICA LIFE INSURANCE COMPANY lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"RIN 1235-AA43, Department of Labor, Wage and Hour Division, Final Rule on Employee or Independent Contractor Classification Under the FairLabor Standards Act; H.R.20/S.567, Richard L. Trumka Protecting the Right to Organize Act of 2023. Federal Trade Commission File Number R111003, Advanced Notice of Proposed Rulemaking on Earnings Claims; RIN 3084-AB04, Federal TradeCommission Regulatory Review and Advanced Notice of Proposed Rulemaking on Business Opportunity Rule P.L. 117-328, Consolidated Appropriations Act of 2023, Division T, SECURE 2.0 Act of 2023; RIN 1210-AC02, Department of Labor, EmployeeBenefits Security Administration, Final Rule, Retirement Security Rule: Definition of an Investment Advice Fiduciary; ZRIN 1210-ZA32,Department of Labor, Employee Benefits Security Administration, Final Amendment to Prohibited Transaction Exemption 2020-02; ZRIN 1210-ZA33, Department of Labor, Employee Benefits Security Administration, Final Amendment to Prohibited Transaction Exemption 84-24; ZRIN 1210-ZA34, Department of Labor, Employee Benefits Security Administration, Final Amendments to Prohibited Transaction Exemptions 75-1, 77-4, 80-83,83-1, and 86-128. RIN 3235-AM87, Securities and Exchange Commission, Final Rule on The Enhancement and Standardization of Climate-Related Disclosures forInvestors; RIN 3235-AN00, Securities and Exchange Commission,Proposed Rule, Conflicts of Interest Associated with the Use of Predictive Data Analytics by Broker-Dealers and Investment Advisers. H.R. 2547/S.__, Secure Family Futures Act of 2025; Business State and Local Tax Deductions related to budget reconcilition and comprehensive tax legislation. S.__/H.R.__, Homebuyers Privacy Protection Act of 2025."
You can find more data on corporate lobbying on Quiver Quantitative.
PRI Congressional Stock Trading
Members of Congress have traded $PRI stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $PRI stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 05/12, 02/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PRI Insider Trading Activity
PRI insiders have traded $PRI stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $PRI stock by insiders over the last 6 months:
- GLENN J. WILLIAMS (Chief Executive Officer) has made 0 purchases and 2 sales selling 5,500 shares for an estimated $1,492,803.
- PETER W. SCHNEIDER (President) has made 0 purchases and 2 sales selling 4,000 shares for an estimated $1,126,538.
- SANJEEV DHEER sold 1,300 shares for an estimated $354,913
- NICHOLAS ADAM JENDUSA (Principal Accounting Officer) sold 234 shares for an estimated $65,554
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PRI Hedge Fund Activity
We have seen 240 institutional investors add shares of PRI stock to their portfolio, and 228 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 442,022 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $120,968,160
- FIRST TRUST ADVISORS LP added 299,219 shares (+1303.7%) to their portfolio in Q1 2025, for an estimated $85,136,782
- AQR CAPITAL MANAGEMENT LLC added 199,715 shares (+171.8%) to their portfolio in Q1 2025, for an estimated $56,824,908
- MILLENNIUM MANAGEMENT LLC removed 128,845 shares (-53.6%) from their portfolio in Q1 2025, for an estimated $36,660,267
- COPELAND CAPITAL MANAGEMENT, LLC added 100,212 shares (+inf%) to their portfolio in Q2 2025, for an estimated $27,425,018
- BALYASNY ASSET MANAGEMENT L.P. removed 65,623 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $18,671,712
- BAMCO INC /NY/ removed 51,617 shares (-3.1%) from their portfolio in Q1 2025, for an estimated $14,686,585
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PRI Price Targets
Multiple analysts have issued price targets for $PRI recently. We have seen 2 analysts offer price targets for $PRI in the last 6 months, with a median target of $305.5.
Here are some recent targets:
- Bob Huang from Morgan Stanley set a target price of $296.0 on 05/19/2025
- Ryan Krueger from Keefe, Bruyette & Woods set a target price of $315.0 on 04/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of MLA ASSOCIATES ON BEHALF OF CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to defense technology including P.L. 119-4 - FY2025 Full-Year Continuing Appropriations and Extensions Act; FY2026 Department o fDefense Appropriations; and FY2025 Budget Reconciliation (H.Con.Res. 14; S.Con.Res. 7). Issues related to defense technology including P.L. 119-4 - FY2025 Full-Year Continuing Appropriations and Extensions Act; FY2026 Department of Defense Appropriations; and FY2025 Budget Reconciliation (H.Con.Res. 14; S.Con.Res. 7)."
You can find more data on corporate lobbying on Quiver Quantitative.
QRVO Insider Trading Activity
QRVO insiders have traded $QRVO stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $QRVO stock by insiders over the last 6 months:
- PHILIP CHESLEY (SVP, High Performance Analog) has made 0 purchases and 2 sales selling 11,375 shares for an estimated $892,877.
- JOHN R HARDING sold 1,450 shares for an estimated $101,630
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
QRVO Hedge Fund Activity
We have seen 199 institutional investors add shares of QRVO stock to their portfolio, and 314 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- STARBOARD VALUE LP added 8,270,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $598,830,700
- PACER ADVISORS, INC. removed 5,100,440 shares (-99.9%) from their portfolio in Q1 2025, for an estimated $369,322,860
- BLACKROCK, INC. removed 2,740,322 shares (-17.2%) from their portfolio in Q1 2025, for an estimated $198,426,716
- MORGAN STANLEY removed 2,617,227 shares (-62.4%) from their portfolio in Q1 2025, for an estimated $189,513,407
- JERICHO CAPITAL ASSET MANAGEMENT L.P. added 2,333,650 shares (+inf%) to their portfolio in Q1 2025, for an estimated $168,979,596
- CAPITAL RESEARCH GLOBAL INVESTORS added 2,254,705 shares (+inf%) to their portfolio in Q1 2025, for an estimated $163,263,189
- CONTOUR ASSET MANAGEMENT LLC added 2,094,993 shares (+inf%) to their portfolio in Q1 2025, for an estimated $151,698,443
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
QRVO Analyst Ratings
Wall Street analysts have issued reports on $QRVO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 06/27/2025
- Benchmark issued a "Buy" rating on 04/30/2025
- Needham issued a "Buy" rating on 04/30/2025
- Citigroup issued a "Sell" rating on 01/29/2025
To track analyst ratings and price targets for QRVO, check out Quiver Quantitative's $QRVO forecast page.
QRVO Price Targets
Multiple analysts have issued price targets for $QRVO recently. We have seen 11 analysts offer price targets for $QRVO in the last 6 months, with a median target of $90.0.
Here are some recent targets:
- Christopher Rolland from Susquehanna set a target price of $90.0 on 07/22/2025
- Timothy Arcuri from UBS set a target price of $95.0 on 07/21/2025
- James Schneider from Goldman Sachs set a target price of $90.0 on 07/10/2025
- Vijay Rakesh from Mizuho set a target price of $84.0 on 07/01/2025
- Harsh Kumar from Piper Sandler set a target price of $110.0 on 06/27/2025
- Tom O'Malley from Barclays set a target price of $70.0 on 04/30/2025
- Gary Mobley from Loop Capital set a target price of $75.0 on 04/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$500,000 of NUCOR CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Affordable and reliable energy supply through development of all resources including clean coal, natural gas, nuclear, wind, solar, and other renewable sources; U.S. supply chain for renewable energy infrastructure. Sustainability of steel produced in the United States in terms of recycled content, recyclability, and emissions and energy intensity reductions; EPA regulatory activities; PM2.5 NAAQS Review; science-based green steel standard focused on reducing GHG emissions regardless of technology; industrial decarbonization in the U.S. through R&D and investment; Federal Buy Clean programs; carbon border policies; permitting reform; EAF slag treatment. Non-unionized workplace and cooperative workplace safety programs. H.R. 3151/S. 1541 SHIPS for America Act of 2025 U.S. manufacturing strategy; domestic supply chains; national security; and job creation. Infrastructure investments; Buy America provisions and waivers; Implementation of Infrastructure Investment and Jobs Act. H.R. 1548/S. 691, Leveling the Playing Field 2.0 Act S. 1325 The Foreign Pollution Fee Act Trade remedy laws and enforcement; industrial subsidies and global markets; disciplines on state-owned enterprises; excess global steel capacity; trade rules for non-market economies; non-tariff barriers to exports; the steel Section 232 program; scrap export restrictions. H.R. 1 One Big Beautiful Bill Act Support innovation, investment, and growth in the manufacturing sector H.R. 3151/S. 1541 SHIPS for America Act of 2025 FY26 Defense Appropriations Bill Support ground vehicle plate development initiative; support defense funding allocation as it relates to shipbuilding."
You can find more data on corporate lobbying on Quiver Quantitative.
NUE Congressional Stock Trading
Members of Congress have traded $NUE stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $NUE stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 03/05 and 1 sale worth up to $50,000 on 03/31.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
NUE Insider Trading Activity
NUE insiders have traded $NUE stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $NUE stock by insiders over the last 6 months:
- LEON J TOPALIAN (Chair, President and CEO) has made 0 purchases and 3 sales selling 34,238 shares for an estimated $4,114,921.
- KENNETH REX QUERY (Executive Vice President) has made 0 purchases and 2 sales selling 10,000 shares for an estimated $1,303,712.
- DANIEL R. NEEDHAM (Executive Vice President) sold 7,088 shares for an estimated $906,342
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NUE Hedge Fund Activity
We have seen 543 institutional investors add shares of NUE stock to their portfolio, and 536 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 3,064,332 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $368,761,712
- DIAMOND HILL CAPITAL MANAGEMENT INC added 1,618,784 shares (+inf%) to their portfolio in Q1 2025, for an estimated $194,804,466
- PENTWATER CAPITAL MANAGEMENT LP added 1,345,000 shares (+1681.2%) to their portfolio in Q1 2025, for an estimated $161,857,300
- FIRST TRUST ADVISORS LP removed 1,327,059 shares (-55.2%) from their portfolio in Q1 2025, for an estimated $159,698,280
- VANGUARD GROUP INC added 745,671 shares (+2.6%) to their portfolio in Q1 2025, for an estimated $89,734,048
- AUSTRALIANSUPER PTY LTD removed 715,332 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $86,083,052
- CITADEL ADVISORS LLC removed 654,291 shares (-86.8%) from their portfolio in Q1 2025, for an estimated $78,737,378
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NUE Analyst Ratings
Wall Street analysts have issued reports on $NUE in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 06/20/2025
- BMO Capital issued a "Outperform" rating on 06/02/2025
- UBS issued a "Buy" rating on 05/29/2025
- JP Morgan issued a "Overweight" rating on 04/16/2025
- Goldman Sachs issued a "Buy" rating on 04/07/2025
To track analyst ratings and price targets for NUE, check out Quiver Quantitative's $NUE forecast page.
NUE Price Targets
Multiple analysts have issued price targets for $NUE recently. We have seen 6 analysts offer price targets for $NUE in the last 6 months, with a median target of $148.0.
Here are some recent targets:
- Bill Peterson from JP Morgan set a target price of $162.0 on 07/14/2025
- Carlos De Alba from Morgan Stanley set a target price of $149.0 on 06/20/2025
- Katja Jancic from BMO Capital set a target price of $145.0 on 06/02/2025
- Curt Woodworth from UBS set a target price of $147.0 on 05/29/2025
- Mike Harris from Goldman Sachs set a target price of $169.0 on 04/07/2025
- Christopher LeFemina from Jefferies set a target price of $135.0 on 01/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$300,000 of ENCOMPASS HEALTH CORPORATION (FKA HEALTHSOUTH CORPORATION) lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Inpatient rehabilitation hospital legislative and regulatory proposals (Medicare); IRF Review Choice Demonstration. Inpatient rehabilitation hospital legislative and regulatory proposals (Medicare); IRF Review Choice Demonstration."
You can find more data on corporate lobbying on Quiver Quantitative.
EHC Insider Trading Activity
EHC insiders have traded $EHC stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $EHC stock by insiders over the last 6 months:
- MARK J TARR (President & CEO) has made 0 purchases and 2 sales selling 118,384 shares for an estimated $14,387,152.
- DOUGLAS E COLTHARP (EVP & Chief Financial Officer) has made 0 purchases and 3 sales selling 43,575 shares for an estimated $5,017,537.
- JOHN PATRICK DARBY (EVP, Gen Counsel & Secretary) sold 10,000 shares for an estimated $1,147,900
- ELISSA JOY CHARBONNEAU (Chief Medical Officer) sold 4,279 shares for an estimated $498,974
- ANDREW L PRICE (Chief Accounting Officer) sold 5,042 shares for an estimated $495,578
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EHC Hedge Fund Activity
We have seen 254 institutional investors add shares of EHC stock to their portfolio, and 254 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CONGRESS ASSET MANAGEMENT CO added 755,862 shares (+inf%) to their portfolio in Q2 2025, for an estimated $92,691,357
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 743,967 shares (-67.0%) from their portfolio in Q1 2025, for an estimated $75,348,977
- BLACKROCK, INC. added 587,947 shares (+6.0%) to their portfolio in Q1 2025, for an estimated $59,547,272
- CITADEL ADVISORS LLC added 506,139 shares (+116.6%) to their portfolio in Q1 2025, for an estimated $51,261,757
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 424,691 shares (+25.6%) to their portfolio in Q1 2025, for an estimated $43,012,704
- THRIVENT FINANCIAL FOR LUTHERANS removed 415,726 shares (-46.8%) from their portfolio in Q1 2025, for an estimated $42,104,729
- WELLINGTON MANAGEMENT GROUP LLP removed 411,836 shares (-10.2%) from their portfolio in Q1 2025, for an estimated $41,710,750
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EHC Analyst Ratings
Wall Street analysts have issued reports on $EHC in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stephens & Co. issued a "Overweight" rating on 06/05/2025
- Keybanc issued a "Overweight" rating on 05/27/2025
- UBS issued a "Buy" rating on 04/28/2025
- RBC Capital issued a "Outperform" rating on 04/28/2025
- Truist Securities issued a "Buy" rating on 04/28/2025
- Barclays issued a "Overweight" rating on 04/25/2025
To track analyst ratings and price targets for EHC, check out Quiver Quantitative's $EHC forecast page.
EHC Price Targets
Multiple analysts have issued price targets for $EHC recently. We have seen 7 analysts offer price targets for $EHC in the last 6 months, with a median target of $130.0.
Here are some recent targets:
- Raj Kumar from Stephens & Co. set a target price of $135.0 on 06/05/2025
- Paul Knight from Keybanc set a target price of $135.0 on 05/27/2025
- Andrew Mok from UBS set a target price of $130.0 on 04/28/2025
- Ben Hendrix from RBC Capital set a target price of $125.0 on 04/28/2025
- David Macdonald from Truist Securities set a target price of $135.0 on 04/28/2025
- Andrew Mok from Barclays set a target price of $129.0 on 04/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$11,000 of RAYONIER lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Forestry Issues"
You can find more data on corporate lobbying on Quiver Quantitative.
RYN Hedge Fund Activity
We have seen 248 institutional investors add shares of RYN stock to their portfolio, and 124 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 3,372,817 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $94,034,137
- BLACKROCK, INC. added 2,300,726 shares (+16.7%) to their portfolio in Q1 2025, for an estimated $64,144,240
- DIAMOND HILL CAPITAL MANAGEMENT INC removed 1,496,049 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $41,709,846
- AQR CAPITAL MANAGEMENT LLC added 1,397,555 shares (+1287.3%) to their portfolio in Q1 2025, for an estimated $38,963,833
- DEUTSCHE BANK AG\ removed 1,209,542 shares (-66.1%) from their portfolio in Q1 2025, for an estimated $33,722,030
- BRITISH COLUMBIA INVESTMENT MANAGEMENT CORP added 971,167 shares (+30.0%) to their portfolio in Q1 2025, for an estimated $27,076,135
- UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH added 845,833 shares (+inf%) to their portfolio in Q1 2025, for an estimated $23,581,824
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
RYN Analyst Ratings
Wall Street analysts have issued reports on $RYN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Outperform" rating on 03/12/2025
To track analyst ratings and price targets for RYN, check out Quiver Quantitative's $RYN forecast page.
RYN Price Targets
Multiple analysts have issued price targets for $RYN recently. We have seen 4 analysts offer price targets for $RYN in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Anthony Pettinari from Citigroup set a target price of $26.0 on 06/03/2025
- Matthew McKellar from RBC Capital set a target price of $27.0 on 05/02/2025
- Michael Roxland from Truist Securities set a target price of $27.0 on 04/22/2025
- Collin Mings from Raymond James set a target price of $31.0 on 03/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$15,000 of JABIL INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"None"
You can find more data on corporate lobbying on Quiver Quantitative.
JBL Insider Trading Activity
JBL insiders have traded $JBL stock on the open market 36 times in the past 6 months. Of those trades, 0 have been purchases and 36 have been sales.
Here’s a breakdown of recent trading of $JBL stock by insiders over the last 6 months:
- MARK T MONDELLO (Executive Chairman) has made 0 purchases and 12 sales selling 190,000 shares for an estimated $34,966,219.
- JOHN C PLANT has made 0 purchases and 2 sales selling 50,000 shares for an estimated $8,627,280.
- STEVEN A RAYMUND has made 0 purchases and 3 sales selling 29,387 shares for an estimated $6,456,261.
- MICHAEL DASTOOR (CEO) has made 0 purchases and 3 sales selling 28,234 shares for an estimated $5,193,741.
- STEVEN D BORGES (EVP, Global Business Units) sold 22,443 shares for an estimated $4,488,824
- ANDREW PRIESTLEY (EVP, Global Business Units) has made 0 purchases and 3 sales selling 17,695 shares for an estimated $3,677,677.
- FREDERIC E. MCCOY (EVP, Operations) sold 8,971 shares for an estimated $1,842,571
- MAY YEE YAP (SVP, Chief Information Officer) sold 6,787 shares for an estimated $1,398,122
- ADAM E. BERRY (SVP, IR and Communications) sold 4,233 shares for an estimated $848,113
- ANOUSHEH ANSARI has made 0 purchases and 2 sales selling 3,500 shares for an estimated $741,683.
- FRANCIS MCKAY (SVP, Chief Procurement Officer) sold 3,395 shares for an estimated $697,620
- CHRISTOPHER S HOLLAND sold 3,400 shares for an estimated $551,728
- GARY K. SCHICK (SVP, CHRO) has made 0 purchases and 2 sales selling 678 shares for an estimated $102,549.
- MATTHEW CROWLEY (EVP, Global Business Units) has made 0 purchases and 3 sales selling 115 shares for an estimated $17,214.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
JBL Hedge Fund Activity
We have seen 398 institutional investors add shares of JBL stock to their portfolio, and 370 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,742,979 shares (-31.5%) from their portfolio in Q1 2025, for an estimated $237,167,152
- ALYESKA INVESTMENT GROUP, L.P. removed 810,727 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $110,315,622
- WELLINGTON MANAGEMENT GROUP LLP added 747,423 shares (+12.9%) to their portfolio in Q1 2025, for an estimated $101,701,847
- JACOBS LEVY EQUITY MANAGEMENT, INC added 662,938 shares (+119.9%) to their portfolio in Q1 2025, for an estimated $90,205,973
- ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. added 623,208 shares (+4593.2%) to their portfolio in Q2 2025, for an estimated $135,921,664
- LORD, ABBETT & CO. LLC added 598,063 shares (+inf%) to their portfolio in Q1 2025, for an estimated $81,378,432
- PACER ADVISORS, INC. added 540,905 shares (+2878.1%) to their portfolio in Q1 2025, for an estimated $73,600,943
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
JBL Analyst Ratings
Wall Street analysts have issued reports on $JBL in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 07/17/2025
- Stifel issued a "Buy" rating on 07/02/2025
- B of A Securities issued a "Buy" rating on 06/20/2025
- Raymond James issued a "Strong Buy" rating on 06/18/2025
- Goldman Sachs issued a "Buy" rating on 06/18/2025
- Barclays issued a "Overweight" rating on 06/17/2025
To track analyst ratings and price targets for JBL, check out Quiver Quantitative's $JBL forecast page.
JBL Price Targets
Multiple analysts have issued price targets for $JBL recently. We have seen 7 analysts offer price targets for $JBL in the last 6 months, with a median target of $230.0.
Here are some recent targets:
- Samik Chatterjee from JP Morgan set a target price of $256.0 on 07/17/2025
- Ruben Roy from Stifel set a target price of $245.0 on 07/02/2025
- Ruplu Bhattacharya from B of A Securities set a target price of $245.0 on 06/20/2025
- Melissa Fairbanks from Raymond James set a target price of $230.0 on 06/18/2025
- Mark Delaney from Goldman Sachs set a target price of $215.0 on 06/18/2025
- David Vogt from UBS set a target price of $208.0 on 06/18/2025
- George Wang from Barclays set a target price of $223.0 on 06/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$70,000 of COEUR MINING INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"mining, federal lands issues"
You can find more data on corporate lobbying on Quiver Quantitative.
CDE Insider Trading Activity
CDE insiders have traded $CDE stock on the open market 9 times in the past 6 months. Of those trades, 3 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $CDE stock by insiders over the last 6 months:
- PIERRE BEAUDOIN has made 0 purchases and 3 sales selling 60,551 shares for an estimated $442,205.
- EDUARDO LUNA sold 17,160 shares for an estimated $134,362
- KENNETH J WATKINSON (VP, Corporate Controller & CAO) sold 12,350 shares for an estimated $91,390
- AOIFE MCGRATH (SVP, Exploration) sold 8,000 shares for an estimated $74,720
- THOMAS S WHELAN (SVP & CFO) purchased 10,000 shares for an estimated $52,500
- PARAMITA DAS has made 2 purchases buying 1,535 shares for an estimated $8,887 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CDE Hedge Fund Activity
We have seen 274 institutional investors add shares of CDE stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 23,303,638 shares (+57.3%) to their portfolio in Q1 2025, for an estimated $137,957,536
- BLACKROCK, INC. added 21,164,211 shares (+54.6%) to their portfolio in Q1 2025, for an estimated $125,292,129
- VAN ECK ASSOCIATES CORP added 14,664,037 shares (+46.2%) to their portfolio in Q1 2025, for an estimated $86,811,099
- STATE STREET CORP added 10,807,823 shares (+63.0%) to their portfolio in Q1 2025, for an estimated $63,982,312
- SPROTT INC. added 10,180,102 shares (+889.3%) to their portfolio in Q1 2025, for an estimated $60,266,203
- MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 7,579,901 shares (+72.5%) to their portfolio in Q1 2025, for an estimated $44,873,013
- GEODE CAPITAL MANAGEMENT, LLC added 5,590,452 shares (+61.4%) to their portfolio in Q1 2025, for an estimated $33,095,475
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CDE Analyst Ratings
Wall Street analysts have issued reports on $CDE in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Roth Capital issued a "Buy" rating on 07/01/2025
- TD Securities issued a "Buy" rating on 03/11/2025
- Roth MKM issued a "Buy" rating on 02/21/2025
- BMO Capital issued a "Outperform" rating on 02/18/2025
To track analyst ratings and price targets for CDE, check out Quiver Quantitative's $CDE forecast page.
CDE Price Targets
Multiple analysts have issued price targets for $CDE recently. We have seen 4 analysts offer price targets for $CDE in the last 6 months, with a median target of $8.625.
Here are some recent targets:
- Joe Reagor from Roth Capital set a target price of $12.0 on 07/01/2025
- An analyst from TD Securities set a target price of $7.0 on 03/11/2025
- Joe Reagor from Roth MKM set a target price of $8.25 on 02/21/2025
- Kevin O'Halloran from BMO Capital set a target price of $9.0 on 02/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$4,460,000 of AMAZON.COM SERVICES LLC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to broadband access and affordability, satellite communications, space safety, device accessibility, Section 230 reform, content moderation, online video, and the Universal Service Fund (USF), including implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58). Issues related to intellectual property, including the NO FAKES Act (S. 1367), counterfeits, music licensing, and issues related to patent reform, International Trade Commission Section patent investigations, intermediary liability, and patent reform, including the RESTORE Patents Act (H.R. 1574 / S. 708). Issues related to cybersecurity, including critical infrastructure protection, payments security, cloud security, authentication, government procurement, cybersecurity incident reporting, and artificial intelligence, including the FY26 National Defense Authorization Act (draft bill - no numbers), and implementation of the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159). Issues related to postal rates, service performance, and the transportation of hazardous materials. Issues related to taxes, digital goods and services, renewable energy tax credits, and international and corporate taxation, including the American Innovation and Jobs Act (S. 1639), H.R. 1 - To provide for reconciliation pursuant to title II of H. Con. Res. 14. (P.L. 119-21), the American Innovation and R&D Competitiveness Act (H.R. 1990), the Growing and Preserving Innovation in America Act of 2025 (H.R. 1062), the United States-Taiwan Expedited Double Tax Relief Act (H.R. 33 / S. 199), and implementation of the Tax Cut and Jobs Act (P.L. 115-97). Issues related to data protection, encryption, data retention, data breach notification, data security, cross border data flows, privacy, law enforcement access, fraud prevention, product safety related to the sale of counterfeit and/or stolen products, including the Combating Organized Retail Crime Act (S. 1404 / H.R. 2853), cloud computing, and implementation of the Consumer Product Safety Improvement Act of 2008 (P.L. 110-314). Issues related to artificial intelligence safety and research and development, including the CREATE AI Act (H.R. 2385). Issues related to cybersecurity, cloud security, IT modernization, and government procurement, including the Department of State Authorization Act 2025 (draft bill - no numbers), the Strengthening Agency Management and Oversight of Software Assets Act (H.R. 1695 / S. 931), the Protecting AI and Cloud Competition in Defense Act of 2025 (H.R. 3434 / S. 1775), the Multi-Cloud Innovation and Advancement Act of 2023 (S. 2871), implementation of the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159), and the Federal Improvement in Technology (FIT) Procurement Act (draft bill - no numbers). Issues related to immigration, high-skilled immigration, and non-immigrant visas, including issues related to employment-based visas, green card backlog, and the STEM visa exemption provision. Issues related to US trade policy, including USMCA, the World Trade Organization, the World Customs Organization, China, country of origin labeling, US customs policy and procedures, US tariffs, foreign direct investment, issues related to domestic semiconductor manufacturing and research, export controls, sanctions, and supply chain, and other trade practices, including in the EU, Asia, and Latin America, the COOL Online Act (S.294), and the ENFORCE Act (draft bill - no numbers). Issues related to STEM education, computer science education, and job training in the CHIPS and Science Act of 2022 (P.L. 117-167), and implementation of the National Defense Authorization Act for Fiscal Year 2024 (P.L. 118-31) and the National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159.) Issues related to technology, procurement, and space policy, including the Streamlining Procurement for Effective Execution and Delivery (SPEED) Act (H.R. 3838), the Fostering Reform and Government Efficiency in Defense Act (draft bill - no numbers), implementation of the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159), and the FoRGED Act (S. 5618) and the FY26 National Defense Authorization Act (draft bill - no numbers). Issues related to IT systems improvements and cloud computing technology, the Intelligence Authorization Act (IAA) for Fiscal Year 2025 (H.R. 8512 / S. 4443), implementation of the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159), and the Intelligence Authorization Act (IAA) for Fiscal Year 2026 (draft bill - no numbers). Issues related to drones and air cargo, including implementation of the Federal Aviation Administration Reauthorization Act of 2024 (P.L. 118-63). Issues related to payment processing, corporate governance, debit reforms, financial innovation and technology, lending, gift cards, money transmission licensing, fraud prevention, payment authentication, data security, the Congressional Review Act resolution to overturn the CFPB larger participant rule (S.J. Res. 18 / H.J. Res. 64), the CFPB open banking rule, the Credit Card Competition Act (H.R. 3881 / S. 1838), the Financial Services and General Government Appropriations Act, 2025 (H.R. 8773), and financial inclusion. Issues related to surface transportation, including autonomous vehicles, alternative fuel vehicles, community infrastructure investments, e-bikes, hazardous materials, U.S. internal supply chain and goods movement, and maritime transportation; issues related to infrastructure, including implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58). Issues related to USDA SNAP online purchasing, including reauthorization of the Agricultural Improvement Act of 2018 (P.L. 115-334), the Farm, Food, and National Security Act of 2024 (H.R. 8467), Electronic Benefit Transfer, the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), and food safety. Issues related to implementation of the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159), and e-commerce opportunities for small businesses. Issues related to veterans hiring and training, employee compensation and benefits, workplace safety, competition, and contracting. and minimum wage. Issues related to IT modernization, cybersecurity, FedRAMP, open data, and government procurement, including implementation of the National Defense Authorization Act for Fiscal Year 2024 (P.L. 118-31), implementation of the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159), implementation of Federal Acquisition Reform; implementation of the Foundations for Evidence-Based Policymaking Act of 2018 (P.L. 115-435), the Continuing Appropriations and Extensions Act of 2025 (H.R. 9747), the Strengthening Agency Management and Oversight of Software Assets Act (H.R. 1695 / S. 931), implementation of the Federal Information Security Management Act (P.L. 107-347), the Multi-Cloud Innovation and Advancement Act of 2023 (H.R. 4891 / S. 2871), the Federal Improvement in Technology (FIT) Procurement Act (H.R. 4123), and implementation of the Federal Artificial Intelligence Risk Management Act of 2023 (P.L. 117-263). Issues related to IT modernization, cloud computing, and IP in general appropriations and the federal budget. Issues related to health information technology, Medicare, healthcare and telehealth, including the Telehealth Expansion Act (H.R. 1650 / S. 763), the Telehealth Benefit Expansion for Workers Act (draft bill - no numbers), the CONNECT for Health Act (S. 1261), the Telehealth Modernization Act (draft bill - no numbers), and the Primary Care Enhancement Act (H.R. 1026), and; issues relating to Medicare payment and accountable care before the Centers for Medicare & Medicaid Services (CMS); issues related to the Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L. 119-4). Issues related to Amazons Climate Pledge, including alternative fuel vehicles, renewable electricity data, data center energy, and issues related to energy and environmental provisions in the Infrastructure Investment and Jobs Act (P.L. 117-58) and the Department of the Interior, Environment, and Related Agencies Appropriations Act, 2025 (draft bill - no numbers)."
You can find more data on corporate lobbying on Quiver Quantitative.
AMZN Congressional Stock Trading
Members of Congress have traded $AMZN stock 40 times in the past 6 months. Of those trades, 29 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $AMZN stock by members of Congress over the last 6 months:
- REPRESENTATIVE CLEO FIELDS has traded it 7 times. They made 7 purchases worth up to $1,600,000 on 06/30, 06/25, 06/09, 06/05 and 0 sales.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 1 purchase worth up to $15,000 on 04/08 and 2 sales worth up to $30,000 on 06/23, 04/03.
- SENATOR JOHN BOOZMAN has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/16, 02/26, 02/04 and 0 sales.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $500,000 on 05/12.
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/08, 04/24, 02/26 and 0 sales.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 4 times. They made 4 purchases worth up to $60,000 on 05/05, 04/08, 04/04, 01/21 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 04/29.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 3 times. They made 1 purchase worth up to $50,000 on 03/03 and 2 sales worth up to $30,000 on 04/21, 03/20.
- REPRESENTATIVE JONATHAN L. JACKSON sold up to $50,000 on 04/16.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE JULIE JOHNSON sold up to $50,000 on 04/07.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
- REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 04/03.
- REPRESENTATIVE GREG LANDSMAN has traded it 3 times. They made 1 purchase worth up to $50,000 on 02/20 and 2 sales worth up to $30,000 on 03/27, 02/26.
- REPRESENTATIVE DAVID TAYLOR purchased up to $15,000 on 03/27.
- REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/20 and 0 sales.
- REPRESENTATIVE SCOTT FRANKLIN has traded it 3 times. They made 3 purchases worth up to $130,000 on 02/26 and 0 sales.
- SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 02/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
AMZN Insider Trading Activity
AMZN insiders have traded $AMZN stock on the open market 67 times in the past 6 months. Of those trades, 0 have been purchases and 67 have been sales.
Here’s a breakdown of recent trading of $AMZN stock by insiders over the last 6 months:
- JEFFREY P BEZOS (Executive Chair) has made 0 purchases and 12 sales selling 14,233,195 shares for an estimated $3,190,035,927.
- DOUGLAS J HERRINGTON (CEO Worldwide Amazon Stores) has made 0 purchases and 19 sales selling 60,732 shares for an estimated $13,374,022.
- DAVID ZAPOLSKY (Senior Vice President) has made 0 purchases and 11 sales selling 45,730 shares for an estimated $9,644,805.
- ANDREW R JASSY (President and CEO) has made 0 purchases and 8 sales selling 40,656 shares for an estimated $8,586,325.
- MATTHEW S GARMAN (CEO Amazon Web Services) has made 0 purchases and 9 sales selling 36,163 shares for an estimated $7,575,082.
- BRIAN T OLSAVSKY (Senior Vice President and CFO) has made 0 purchases and 2 sales selling 32,370 shares for an estimated $6,840,174.
- SHELLEY REYNOLDS (Vice President) has made 0 purchases and 5 sales selling 11,528 shares for an estimated $2,506,235.
- KEITH BRIAN ALEXANDER sold 1,000 shares for an estimated $210,680
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMZN Hedge Fund Activity
We have seen 2,791 institutional investors add shares of AMZN stock to their portfolio, and 2,295 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 132,616,953 shares (+542733.6%) to their portfolio in Q2 2025, for an estimated $29,094,833,318
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 57,137,962 shares (-86.6%) from their portfolio in Q1 2025, for an estimated $10,871,068,650
- GAMMA INVESTING LLC removed 30,063,218 shares (-99.4%) from their portfolio in Q2 2025, for an estimated $6,595,569,397
- INFINITUM ASSET MANAGEMENT, LLC added 23,782,500 shares (+inf%) to their portfolio in Q1 2025, for an estimated $4,524,858,450
- JPMORGAN CHASE & CO added 17,347,225 shares (+9.5%) to their portfolio in Q1 2025, for an estimated $3,300,483,028
- BLACKROCK, INC. added 14,821,685 shares (+2.2%) to their portfolio in Q1 2025, for an estimated $2,819,973,788
- FISHER ASSET MANAGEMENT, LLC removed 12,580,834 shares (-27.9%) from their portfolio in Q1 2025, for an estimated $2,393,629,476
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AMZN Analyst Ratings
Wall Street analysts have issued reports on $AMZN in the last several months. We have seen 36 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 07/22/2025
- Scotiabank issued a "Sector Outperform" rating on 07/22/2025
- Needham issued a "Buy" rating on 07/22/2025
- Cantor Fitzgerald issued a "Overweight" rating on 07/16/2025
- JP Morgan issued a "Overweight" rating on 07/11/2025
- Piper Sandler issued a "Overweight" rating on 07/11/2025
- Morgan Stanley issued a "Overweight" rating on 07/10/2025
To track analyst ratings and price targets for AMZN, check out Quiver Quantitative's $AMZN forecast page.
AMZN Price Targets
Multiple analysts have issued price targets for $AMZN recently. We have seen 39 analysts offer price targets for $AMZN in the last 6 months, with a median target of $250.0.
Here are some recent targets:
- Nat Schindler from Scotiabank set a target price of $275.0 on 07/22/2025
- Brian Pitz from BMO Capital set a target price of $270.0 on 07/22/2025
- Ronald Josey from Citigroup set a target price of $265.0 on 07/22/2025
- Laura Martin from Needham set a target price of $265.0 on 07/22/2025
- Colin Sebastian from Baird set a target price of $244.0 on 07/21/2025
- Deepak Mathivanan from Cantor Fitzgerald set a target price of $260.0 on 07/16/2025
- Doug Anmuth from JP Morgan set a target price of $255.0 on 07/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$320,000 of ENBRIDGE (U.S.) INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Implementation of Issues related to pipeline safety regulation of transmission and gathering systems and pipeline safety reauthorization Energy Infrastructure Permitting, Surface Transportation Reauthorization, and Infrastructure Bills: Lobbied generally on legislation to enhance natural gas and liquids pipeline infrastructure permitting Federal policy relating to 2023 reauthorization of the Pipeline and Hazardous Materials Safety Administration (PHMSA). H.R. 7073 Next Generation Pipelines Research and Development Act H.R. 7023, the Creating Confidence in Clean Water Permitting Act, H.R. 7655, the Pipeline Safety, Modernization and Expansion Act, H.R. 1, Lower Energy Costs Act S. 1456, Spur Permitting of Underdeveloped Resources (SPUR) Act H.R. 4366, Consolidated Appropriations Act, 2024 H.R. 6009 (118), Restoring American Energy Dominance Act H.R. 6494, the Promoting Innovation in Pipeline Efficiency and Safety (PIPES) Act of 2023 H.R. 7024 Tax Relief for American Families and Workers Act Furthering technology deployment and use of composite materials on pipelines H.R. 7073 Next Generation Pipelines Research and Development Act H.R. 7023, the Creating Confidence in Clean Water Permitting Act, H.R. 7655, the Pipeline Safety, Modernization and Expansion Act, H.R. 1, Lower Energy Costs Act S. 1456, Spur Permitting of Underdeveloped Resources (SPUR) Act H.R. 4366, Consolidated Appropriations Act, 2024 H.R. 6009 (118), Restoring American Energy Dominance Act H.R. 6494, the Promoting Innovation in Pipeline Efficiency and Safety (PIPES) Act of 2023 H.R. 7024 Tax Relief for American Families and Workers Act Issues related to Tribal equity partnerships in energy development. H.R. 1 - One big Beautiful Bill Act H.Con.Res 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal year 2026 through 2034. H.R. 7024 Tax Relief for American Families and Workers Act Implementation of Inflation Reduction Act tax provisions and guidance including Corporate Alternative Minimum Tax Department of Treasury Notice 2023-7 General corporate tax issues and provisions related to energy investments. Issues related to methane emissions and permitting of pipeline and midstream infrastructure; implementation of Good Neighbor rule from EPA; legislation to restrict or discourage natural gas production; issues related to 401 permits of the Federal Water Pollution Control Act. Issues related to National Environmental Policy Act reform Lobbied generally regarding the role of natural gas infrastructure in achieving climate goals, including bills to promote innovation and investment in hydrogen, renewable natural gas, and CCUS infrastructure Lobbied generally regarding potential proposals for methane emissions legislation Federal policy relating to the Federal Water Pollution Control Act (P.L. 92-500). H.R. 1152, Water Quality Certification and Energy Project Improvement Act of 2023 (provisions relating to the interstate natural gas pipeline infrastructure sector). H.R. 1335 - Transparency, Accountability, Permitting, and Production of American Resources Act (provisions relating to the interstate natural gas pipeline infrastructure sector). H.R. 1577, Building United States Infrastructure through Limited Delays and Efficient Reviews (BUILDER) Act of 2023 (provisions relating to the interstate natural gas pipeline infrastructure sector). S. 5165, Pipeline Permitting for Energy Security Act of 2022 (provisions relating to the interstate natural gas pipeline infrastructure sector). H.R. 5376, Inflation Reduction Act of 2022 (provisions relating to the interstate natural gas pipeline infrastructure sector) (P.L. 117-169). H.R. 7023, the Creating Confidence in Clean Water Permitting Act, H.R. 7655, the Pipeline Safety, Modernization and Expansion Act, S. 1456, Spur Permitting of Underdeveloped Resources (SPUR) Act H.R. 4366, Consolidated Appropriations Act, 2024 H.R. 6009 (118), Restoring American Energy Dominance Act Issues related to the role of natural gas in energy policy; issues related to permitting of pipeline and midstream infrastructure; oppose legislation to restrict or discourage natural gas production. Legislation: H.R. 1, Lower Energy Costs Act (provisions relating to permitting energy infrastructure sector, National Environmental Policy Act). H.R. 7073 Next Generation Pipelines Research and Development Act H.R. 7023, the Creating Confidence in Clean Water Permitting Act, H.R. 7655, the Pipeline Safety, Modernization and Expansion Act, S. 1456, Spur Permitting of Underdeveloped Resources (SPUR) Act H.R. 4366, Consolidated Appropriations Act, 2024 H.R. 6009 (118), Restoring American Energy Dominance Act H.R. 6494, the Promoting Innovation in Pipeline Efficiency and Safety (PIPES) Act of 2023 Issues related to physical, chemical, and cyber security and their impacts on pipeline and midstream infrastructure Lobbied generally regarding proposals for critical infrastructure cybersecurity incident reporting and oversight legislation Cybersecurity legislation and proposals relating to physical security, including S. 1605, National Defense Authorization Act for Fiscal Year (FY) 2022; H.R. 7900, National Defense Authorization Act for Fiscal Year (FY) 2023; S. 3600, Strengthening American Cybersecurity Act of 2022; H.R. 3078, Pipeline and LNG Facility Cybersecurity Preparedness Act; H.R. 6084, Energy Product Reliability Act; and S. 3600, Strengthening American Cybersecurity Act of 2022. Advanced Notice of Proposed Rulemaking on Enhancing Surface Cyber Risk Management (TSA-2022-0001). Issues related to appropriations of funds for agencies involved in pipeline operations permitting/ safety oversight FY 2024 Transportation, Housing, and Urban Development Funding Bill, all provisions related to pipeline safety. FY 2024 Energy & Water Development and Related Agencies Funding Bill, all provisions related to U.S. Army Corps of Engineers. H.R. 4366, Consolidated Appropriations Act, 2024 H.R. 7024 Tax Relief for American Families and Workers Act"
You can find more data on corporate lobbying on Quiver Quantitative.
ENB Hedge Fund Activity
We have seen 590 institutional investors add shares of ENB stock to their portfolio, and 538 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GOLDMAN SACHS GROUP INC added 18,579,027 shares (+129.7%) to their portfolio in Q1 2025, for an estimated $823,236,686
- BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 13,778,577 shares (-76.4%) from their portfolio in Q1 2025, for an estimated $610,528,746
- FIL LTD added 9,346,081 shares (+92.7%) to their portfolio in Q1 2025, for an estimated $414,124,849
- NATIONAL BANK OF CANADA /FI/ removed 6,184,224 shares (-32.1%) from their portfolio in Q1 2025, for an estimated $274,022,965
- MACQUARIE GROUP LTD added 4,765,935 shares (+16421.8%) to their portfolio in Q1 2025, for an estimated $211,178,579
- BLACKSTONE INC. added 3,920,016 shares (+68.6%) to their portfolio in Q1 2025, for an estimated $173,695,908
- BANK OF NOVA SCOTIA removed 3,851,073 shares (-35.0%) from their portfolio in Q1 2025, for an estimated $170,641,044
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ENB Analyst Ratings
Wall Street analysts have issued reports on $ENB in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 05/12/2025
- CIBC issued a "Outperformer" rating on 03/05/2025
To track analyst ratings and price targets for ENB, check out Quiver Quantitative's $ENB forecast page.
ENB Price Targets
Multiple analysts have issued price targets for $ENB recently. We have seen 5 analysts offer price targets for $ENB in the last 6 months, with a median target of $65.0.
Here are some recent targets:
- Theresa Chen from Barclays set a target price of $65.0 on 06/03/2025
- Maurice Choy from RBC Capital set a target price of $67.0 on 05/12/2025
- Robert Catellier from CIBC set a target price of $67.0 on 03/05/2025
- Robert Hope from Scotiabank set a target price of $65.0 on 02/13/2025
- Anthony Linton from Jefferies set a target price of $65.0 on 01/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$10,000 of DT MIDSTREAM INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"GREET model, energy policy"
You can find more data on corporate lobbying on Quiver Quantitative.
DTM Congressional Stock Trading
Members of Congress have traded $DTM stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DTM stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
DTM Insider Trading Activity
DTM insiders have traded $DTM stock on the open market 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $DTM stock by insiders over the last 6 months:
- WENDY ELLIS (E.V.P., Gen Counsel & Corp Sec) has made 0 purchases and 2 sales selling 18,854 shares for an estimated $1,753,804.
- ROBERT C JR SKAGGS purchased 1,000 shares for an estimated $86,920
- JEFFREY A JEWELL (Executive V.P., CFO) has made 2 purchases buying 235 shares for an estimated $22,946 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DTM Hedge Fund Activity
We have seen 299 institutional investors add shares of DTM stock to their portfolio, and 232 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 1,919,675 shares (-89.6%) from their portfolio in Q1 2025, for an estimated $185,210,244
- BLACKSTONE INC. added 1,604,973 shares (+98.4%) to their portfolio in Q1 2025, for an estimated $154,847,795
- STANDARD INVESTMENTS LLC removed 965,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $93,103,200
- NEUBERGER BERMAN GROUP LLC added 785,501 shares (+50.0%) to their portfolio in Q1 2025, for an estimated $75,785,136
- FMR LLC removed 733,050 shares (-92.6%) from their portfolio in Q1 2025, for an estimated $70,724,664
- DIMENSIONAL FUND ADVISORS LP removed 685,433 shares (-18.4%) from their portfolio in Q1 2025, for an estimated $66,130,575
- BROOKFIELD CORP /ON/ removed 623,704 shares (-64.4%) from their portfolio in Q1 2025, for an estimated $60,174,961
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DTM Analyst Ratings
Wall Street analysts have issued reports on $DTM in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Underweight" rating on 06/03/2025
- UBS issued a "Buy" rating on 03/27/2025
- B of A Securities issued a "Buy" rating on 03/24/2025
- Wells Fargo issued a "Overweight" rating on 02/28/2025
- Stifel issued a "Buy" rating on 02/27/2025
- Raymond James issued a "Outperform" rating on 01/28/2025
To track analyst ratings and price targets for DTM, check out Quiver Quantitative's $DTM forecast page.
DTM Price Targets
Multiple analysts have issued price targets for $DTM recently. We have seen 8 analysts offer price targets for $DTM in the last 6 months, with a median target of $112.5.
Here are some recent targets:
- Robert Kad from Morgan Stanley set a target price of $115.0 on 06/03/2025
- Theresa Chen from Barclays set a target price of $103.0 on 05/20/2025
- Manav Gupta from UBS set a target price of $115.0 on 03/27/2025
- Jean Ann Salisbury from B of A Securities set a target price of $110.0 on 03/24/2025
- Michael Blum from Wells Fargo set a target price of $108.0 on 02/28/2025
- Selman Akyol from Stifel set a target price of $102.0 on 02/27/2025
- Justin Jenkins from Raymond James set a target price of $115.0 on 01/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of HENRY SCHEIN lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Oral and dental care coverage."
You can find more data on corporate lobbying on Quiver Quantitative.
HSIC Congressional Stock Trading
Members of Congress have traded $HSIC stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HSIC stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 03/31.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HSIC Insider Trading Activity
HSIC insiders have traded $HSIC stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HSIC stock by insiders over the last 6 months:
- BRADFORD C CONNETT (CEO, NA Distribution Group) sold 4,036 shares for an estimated $287,161
- PHILIP A LASKAWY sold 2,604 shares for an estimated $184,998
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HSIC Hedge Fund Activity
We have seen 245 institutional investors add shares of HSIC stock to their portfolio, and 291 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KOHLBERG KRAVIS ROBERTS & CO. L.P. added 12,016,714 shares (+inf%) to their portfolio in Q1 2025, for an estimated $823,024,741
- GENERATION INVESTMENT MANAGEMENT LLP removed 2,743,909 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $187,930,327
- HUDSON BAY CAPITAL MANAGEMENT LP removed 1,465,007 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $100,338,329
- PALESTRA CAPITAL MANAGEMENT LLC added 1,355,154 shares (+51.2%) to their portfolio in Q1 2025, for an estimated $92,814,497
- ING GROEP NV removed 1,151,398 shares (-99.0%) from their portfolio in Q1 2025, for an estimated $78,859,249
- NUANCE INVESTMENTS, LLC removed 1,058,703 shares (-53.8%) from their portfolio in Q1 2025, for an estimated $72,510,568
- ROYAL BANK OF CANADA removed 965,767 shares (-92.1%) from their portfolio in Q1 2025, for an estimated $66,145,381
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HSIC Analyst Ratings
Wall Street analysts have issued reports on $HSIC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 05/06/2025
- Piper Sandler issued a "Overweight" rating on 04/30/2025
To track analyst ratings and price targets for HSIC, check out Quiver Quantitative's $HSIC forecast page.
HSIC Price Targets
Multiple analysts have issued price targets for $HSIC recently. We have seen 6 analysts offer price targets for $HSIC in the last 6 months, with a median target of $77.5.
Here are some recent targets:
- Jeff Johnson from Baird set a target price of $72.0 on 07/14/2025
- Ross Muken from Evercore ISI Group set a target price of $78.0 on 07/09/2025
- Vik Chopra from Wells Fargo set a target price of $75.0 on 05/06/2025
- Michael Petusky from Barrington Research set a target price of $86.0 on 05/06/2025
- Jason Bednar from Piper Sandler set a target price of $77.0 on 04/30/2025
- Kevin Caliendo from UBS set a target price of $80.0 on 02/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of AGIOS PHARMACEUTICALS lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Sickle Cell policy Biotech innovation Medicaid reform Biotech innovation"
You can find more data on corporate lobbying on Quiver Quantitative.
AGIO Congressional Stock Trading
Members of Congress have traded $AGIO stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AGIO stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/17, 01/29 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
AGIO Insider Trading Activity
AGIO insiders have traded $AGIO stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $AGIO stock by insiders over the last 6 months:
- BRIAN GOFF (Chief Executive Officer) has made 0 purchases and 4 sales selling 31,647 shares for an estimated $1,087,334.
- SARAH GHEUENS (Chief Medical Officer) has made 0 purchases and 7 sales selling 22,919 shares for an estimated $832,296.
- JACQUALYN A FOUSE sold 7,497 shares for an estimated $194,172
- TSVETA MILANOVA (Chief Commercial Officer) has made 0 purchases and 2 sales selling 4,451 shares for an estimated $152,648.
- JAMES WILLIAM BURNS (Chief Legal Officer) sold 2,799 shares for an estimated $93,878
- THEODORE JAMES JR. WASHBURN (Principal Accounting Officer) sold 2,272 shares for an estimated $78,134
- CECILIA JONES (Chief Financial Officer) sold 1,780 shares for an estimated $59,701
- DAVID SCADDEN sold 1,400 shares for an estimated $56,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AGIO Hedge Fund Activity
We have seen 103 institutional investors add shares of AGIO stock to their portfolio, and 114 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COMMODORE CAPITAL LP added 2,185,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $64,020,500
- JEFFERIES FINANCIAL GROUP INC. removed 1,500,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $43,950,000
- BVF INC/IL removed 1,073,755 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $31,461,021
- BANK OF AMERICA CORP /DE/ added 730,690 shares (+180.5%) to their portfolio in Q1 2025, for an estimated $21,409,217
- SCS CAPITAL MANAGEMENT LLC added 611,098 shares (+inf%) to their portfolio in Q1 2025, for an estimated $17,905,171
- CITADEL ADVISORS LLC removed 570,177 shares (-39.8%) from their portfolio in Q1 2025, for an estimated $16,706,186
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 440,000 shares (+145.2%) to their portfolio in Q1 2025, for an estimated $12,892,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AGIO Analyst Ratings
Wall Street analysts have issued reports on $AGIO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 07/22/2025
- Scotiabank issued a "Sector Outperform" rating on 05/02/2025
- HC Wainwright & Co. issued a "Buy" rating on 02/24/2025
To track analyst ratings and price targets for AGIO, check out Quiver Quantitative's $AGIO forecast page.
AGIO Price Targets
Multiple analysts have issued price targets for $AGIO recently. We have seen 3 analysts offer price targets for $AGIO in the last 6 months, with a median target of $58.0.
Here are some recent targets:
- Greg Harrison from B of A Securities set a target price of $51.0 on 07/22/2025
- Greg Harrison from Scotiabank set a target price of $71.0 on 05/02/2025
- Emily Bodnar from HC Wainwright & Co. set a target price of $58.0 on 02/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$260,000 of PROLOGIS L.P. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Implementation of electric vehicle charging provisions and emissions reducing provisions included in the Infrastructure Investment and Jobs Act; impact of tariffs on supply chains and freight movement; supply chain optimization; supply chain issues generally Medium and heavy duty electric vehicle charging policy and solar development policy in general; implementation of Infrastructure Investment and Jobs Act; Issues related to AI/datacenters and energy supply H.R. 1, the One Big Beautiful Bill Act, including preservation of the tech-neutral energy investment tax credit (Sec 48E), alternative fuel refueling credit (Sec 30C), and direct pay conversion of energy credits; potential changes to business "SALT" tax treatment; and proposed Section 899 provisions addressing unfair foreign taxes Intermodal transportation issues generally (ports, rail, highways); issues related to FAA-owned land Monitor Administration actions as part of the America First Trade Policy including specific trade actions on Canada, Mexico, China, as well as proposed reciprocal tariffs on a broad list of countries; sector specific tariffs on automobiles; steel and aluminum; and additional potential sector specific tariffs and fees on Chinese cargo shipping Indirect source rules"
You can find more data on corporate lobbying on Quiver Quantitative.
PLD Congressional Stock Trading
Members of Congress have traded $PLD stock 6 times in the past 6 months. Of those trades, 3 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $PLD stock by members of Congress over the last 6 months:
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 06/30, 04/24 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/29.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 02/24 and 1 sale worth up to $50,000 on 04/07.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PLD Insider Trading Activity
PLD insiders have traded $PLD stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PLD stock by insiders over the last 6 months:
- JOSEPH GHAZAL (Chief Investment Officer) sold 10,997 shares for an estimated $1,305,783
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PLD Hedge Fund Activity
We have seen 751 institutional investors add shares of PLD stock to their portfolio, and 661 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 9,187,364 shares (-86.3%) from their portfolio in Q1 2025, for an estimated $1,027,055,421
- COHEN & STEERS, INC. removed 3,235,506 shares (-11.4%) from their portfolio in Q1 2025, for an estimated $361,697,215
- CAPITAL RESEARCH GLOBAL INVESTORS added 3,020,339 shares (+24.5%) to their portfolio in Q1 2025, for an estimated $337,643,696
- WELLS FARGO & COMPANY/MN added 2,550,442 shares (+92.6%) to their portfolio in Q1 2025, for an estimated $285,113,911
- MORGAN STANLEY added 2,497,937 shares (+13.4%) to their portfolio in Q1 2025, for an estimated $279,244,377
- FMR LLC added 2,245,673 shares (+12.6%) to their portfolio in Q1 2025, for an estimated $251,043,784
- CANADA PENSION PLAN INVESTMENT BOARD removed 2,054,186 shares (-41.5%) from their portfolio in Q1 2025, for an estimated $229,637,452
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PLD Analyst Ratings
Wall Street analysts have issued reports on $PLD in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 05/19/2025
- Scotiabank issued a "Sector Underperform" rating on 05/12/2025
- Baird issued a "Outperform" rating on 05/07/2025
- Truist Securities issued a "Buy" rating on 05/05/2025
- Barclays issued a "Overweight" rating on 04/30/2025
- UBS issued a "Buy" rating on 01/28/2025
To track analyst ratings and price targets for PLD, check out Quiver Quantitative's $PLD forecast page.
PLD Price Targets
Multiple analysts have issued price targets for $PLD recently. We have seen 9 analysts offer price targets for $PLD in the last 6 months, with a median target of $119.0.
Here are some recent targets:
- Brent Dilts from UBS set a target price of $120.0 on 07/08/2025
- Blaine Heck from Wells Fargo set a target price of $119.0 on 05/19/2025
- Nicholas Yulico from Scotiabank set a target price of $100.0 on 05/12/2025
- David Rodgers from Baird set a target price of $120.0 on 05/07/2025
- Ki Bin Kim from Truist Securities set a target price of $120.0 on 05/05/2025
- Anthony Powell from Barclays set a target price of $119.0 on 04/30/2025
- Michael Carroll from RBC Capital set a target price of $117.0 on 04/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$30,000 of GRAFTECH INTERNATIONAL LTD. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Educated and raised concerns related to the Section 232 Investigation of Processed Critical Minerals and Derivative Products."
You can find more data on corporate lobbying on Quiver Quantitative.
EAF Insider Trading Activity
EAF insiders have traded $EAF stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EAF stock by insiders over the last 6 months:
- TIMOTHY K FLANAGAN (CEO and President) purchased 50,000 shares for an estimated $53,645
- RORY F. O'DONNELL (Chief Financial Officer & SVP) purchased 50,000 shares for an estimated $51,949
- SACHIN M SHIVARAM has made 2 purchases buying 50,000 shares for an estimated $42,300 and 0 sales.
- JEAN-MARC GERMAIN purchased 50,000 shares for an estimated $39,000
- ERIC V ROEGNER has made 2 purchases buying 325 shares for an estimated $359 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EAF Hedge Fund Activity
We have seen 64 institutional investors add shares of EAF stock to their portfolio, and 73 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 30,467,501 shares (-85.0%) from their portfolio in Q1 2025, for an estimated $26,640,782
- MARATHON ASSET MANAGEMENT LP added 17,558,586 shares (+1003.4%) to their portfolio in Q1 2025, for an estimated $15,353,227
- MORGAN STANLEY added 9,182,932 shares (+654.3%) to their portfolio in Q1 2025, for an estimated $8,029,555
- GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC removed 6,667,836 shares (-37.2%) from their portfolio in Q1 2025, for an estimated $5,830,355
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 2,872,382 shares (-64.4%) from their portfolio in Q1 2025, for an estimated $2,511,610
- GOLDMAN SACHS GROUP INC removed 1,800,775 shares (-57.1%) from their portfolio in Q1 2025, for an estimated $1,574,597
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. added 1,639,250 shares (+inf%) to their portfolio in Q1 2025, for an estimated $1,433,360
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EAF Price Targets
Multiple analysts have issued price targets for $EAF recently. We have seen 3 analysts offer price targets for $EAF in the last 6 months, with a median target of $1.5.
Here are some recent targets:
- Andrew Jones from UBS set a target price of $0.8 on 05/13/2025
- Arun Viswanathan from RBC Capital set a target price of $2.0 on 02/10/2025
- Katja Jancic from BMO Capital set a target price of $1.5 on 02/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$22,500 of 908 DEVICES INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"FY26 CJS Appropriations - Law Enforcement Funding FY26 DOD Appropriations - Air Force and Navy Funding Border Technology Funding Navy and Air Force Technology Funding Law Enforcement Funding"
You can find more data on corporate lobbying on Quiver Quantitative.
MASS Insider Trading Activity
MASS insiders have traded $MASS stock on the open market 20 times in the past 6 months. Of those trades, 4 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $MASS stock by insiders over the last 6 months:
- MICHAEL S. TURNER (Chief Legal & Admin Officer) has made 0 purchases and 6 sales selling 34,275 shares for an estimated $207,287.
- KEVIN J. KNOPP (President and CEO) has made 2 purchases buying 30,000 shares for an estimated $131,383 and 3 sales selling 16,001 shares for an estimated $37,109.
- JOSEPH H. IV GRIFFITH (Chief Financial Officer) has made 0 purchases and 4 sales selling 17,176 shares for an estimated $73,119.
- MARK SPOTO has made 2 purchases buying 10,000 shares for an estimated $42,850 and 0 sales.
- CHRISTOPHER D. BROWN (Chief Product Officer) has made 0 purchases and 3 sales selling 7,767 shares for an estimated $18,190.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MASS Hedge Fund Activity
We have seen 51 institutional investors add shares of MASS stock to their portfolio, and 36 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AWM INVESTMENT COMPANY, INC. added 3,526,000 shares (+210.6%) to their portfolio in Q1 2025, for an estimated $15,796,480
- AMERIPRISE FINANCIAL INC removed 1,814,187 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $8,127,557
- FIRST LIGHT ASSET MANAGEMENT, LLC added 1,701,095 shares (+inf%) to their portfolio in Q1 2025, for an estimated $7,620,905
- INVESCO LTD. added 649,630 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,910,342
- GRANAHAN INVESTMENT MANAGEMENT, LLC removed 522,786 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,342,081
- ESSEX INVESTMENT MANAGEMENT CO LLC added 480,549 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,152,859
- MORGAN STANLEY added 265,041 shares (+99.4%) to their portfolio in Q1 2025, for an estimated $1,187,383
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of WASHINGTON TAX & PUBLIC POLICY GROUP ON BEHALF OF LEGGETT & PLATT INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to international trade and tariffs. Issues related to steel tariffs. Issues related to trade enforcement. Issues related to trade with Southeast Asia."
You can find more data on corporate lobbying on Quiver Quantitative.
LEG Hedge Fund Activity
We have seen 150 institutional investors add shares of LEG stock to their portfolio, and 178 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 10,490,032 shares (-85.9%) from their portfolio in Q1 2025, for an estimated $82,976,153
- MILLENNIUM MANAGEMENT LLC added 4,084,866 shares (+784.7%) to their portfolio in Q1 2025, for an estimated $32,311,290
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC removed 3,291,148 shares (-69.3%) from their portfolio in Q1 2025, for an estimated $26,032,980
- MARSHALL WACE, LLP added 1,880,195 shares (+308.1%) to their portfolio in Q1 2025, for an estimated $14,872,342
- CUBIST SYSTEMATIC STRATEGIES, LLC added 1,443,257 shares (+1495.6%) to their portfolio in Q1 2025, for an estimated $11,416,162
- HRT FINANCIAL LP added 1,368,496 shares (+inf%) to their portfolio in Q1 2025, for an estimated $10,824,803
- BLACKROCK, INC. removed 1,267,759 shares (-7.1%) from their portfolio in Q1 2025, for an estimated $10,027,973
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LEG Price Targets
Multiple analysts have issued price targets for $LEG recently. We have seen 3 analysts offer price targets for $LEG in the last 6 months, with a median target of $9.0.
Here are some recent targets:
- Susan Maklari from Goldman Sachs set a target price of $9.0 on 04/30/2025
- Mike Hickey from Piper Sandler set a target price of $9.0 on 04/11/2025
- Keith Hughes from Truist Securities set a target price of $11.0 on 01/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$260,000 of AECOM lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Funding and policy for water resource investments. Appropriations to support Water Resources Development Act programs and projects. US Army Corps WIFIA program eligibility. US Army Corps Contracting issues. Investments and policy related to implementation of digital technologies in administration of environmental reviews and permitting. Funding and policy related to harmful algal bloom clean up. Issues related to federal facilities. Issues relating to international trade in engineering services. FY 2026 Appropriations for Defense, Military Construction, Transportation HUD, Interior-EPA, Energy and Water, Homeland Security, and State, Foreign Operations. Funding, programs and projects pertaining to transportation and infrastructure investment, including funding for public transportation, rail and water, environmental programs and FEMA. Program requirements for the Department of State related to the ongoing conflict in Ukraine. Provisions related to harmful algal bloom mitigation. Provisions related to digital applications for NEPA environmental reviews and public engagement. Supplemental appropriations related to domestic disaster assistance. Funding for State Department infrastructure programs. Funding, programs and projects pertaining to transportation and infrastructure investment, including funding for aviation, highways, public transportation and rail. Issues related to train station improvements. Legislation to support digital applications for NEPA environmental reviews and public engagement for the Federal Highway Administration, including HR 4621, Interactive Federal Review Act (H.R.4621/S.2319). Issues related to the digital delivery of 3D models of infrastructure project designs. Funding for FEMA and Disaster Relief efforts, including pre-disaster mitigation grants and Stafford Act policy. Supplemental appropriations for domestic disaster assistance. Appropriations for Defense and Military Construction for Fiscal Year 2026. Issues related to Base Realignment and Closure funding and policy. Issues related to Defense department contracting."
You can find more data on corporate lobbying on Quiver Quantitative.
ACM Hedge Fund Activity
We have seen 276 institutional investors add shares of ACM stock to their portfolio, and 264 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST TRUST ADVISORS LP added 2,095,974 shares (+317.1%) to their portfolio in Q1 2025, for an estimated $194,359,669
- PRIMECAP MANAGEMENT CO/CA/ removed 1,232,852 shares (-10.8%) from their portfolio in Q1 2025, for an estimated $114,322,365
- MANUFACTURERS LIFE INSURANCE COMPANY, THE added 756,859 shares (+421.9%) to their portfolio in Q1 2025, for an estimated $70,183,535
- FINDLAY PARK PARTNERS LLP removed 737,800 shares (-41.0%) from their portfolio in Q1 2025, for an estimated $68,416,194
- ALLIANCEBERNSTEIN L.P. removed 696,438 shares (-18.7%) from their portfolio in Q1 2025, for an estimated $64,580,695
- BLACKROCK, INC. removed 662,345 shares (-4.2%) from their portfolio in Q1 2025, for an estimated $61,419,251
- UBS GROUP AG added 617,833 shares (+61.6%) to their portfolio in Q1 2025, for an estimated $57,291,654
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ACM Analyst Ratings
Wall Street analysts have issued reports on $ACM in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 07/16/2025
- RBC Capital issued a "Outperform" rating on 05/07/2025
- Citigroup issued a "Buy" rating on 05/07/2025
- Baird issued a "Outperform" rating on 05/06/2025
- Truist Securities issued a "Buy" rating on 04/08/2025
- Barclays issued a "Overweight" rating on 02/06/2025
To track analyst ratings and price targets for ACM, check out Quiver Quantitative's $ACM forecast page.
ACM Price Targets
Multiple analysts have issued price targets for $ACM recently. We have seen 7 analysts offer price targets for $ACM in the last 6 months, with a median target of $121.0.
Here are some recent targets:
- Eric Heath from Keybanc set a target price of $129.0 on 07/16/2025
- Sabahat Khan from RBC Capital set a target price of $126.0 on 05/07/2025
- Andrew Kaplowitz from Citigroup set a target price of $122.0 on 05/07/2025
- Andrew Wittmann from Baird set a target price of $118.0 on 05/06/2025
- Jamie Cook from Truist Securities set a target price of $121.0 on 04/08/2025
- Adam Seiden from Barclays set a target price of $120.0 on 02/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of HEICO PARTS GROUP INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to DOD acquisition reforms. Implementation of Sec. 161 of P.L. 118-159. Issues related to Sec. 232 investigation on aircraft and aircraft parts."
You can find more data on corporate lobbying on Quiver Quantitative.
HEI.A Congressional Stock Trading
Members of Congress have traded $HEI.A stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HEI.A stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 03/13 and 1 sale worth up to $50,000 on 04/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HEI.A Hedge Fund Activity
We have seen 266 institutional investors add shares of HEI.A stock to their portfolio, and 215 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AUSTRALIANSUPER PTY LTD removed 373,654 shares (-42.3%) from their portfolio in Q1 2025, for an estimated $78,829,784
- INVESTMENT MANAGEMENT CORP OF ONTARIO added 369,138 shares (+inf%) to their portfolio in Q1 2025, for an estimated $77,877,043
- MANNING & NAPIER ADVISORS LLC added 321,096 shares (+443.8%) to their portfolio in Q1 2025, for an estimated $67,741,623
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 234,798 shares (+96.7%) to their portfolio in Q1 2025, for an estimated $49,535,334
- ARISTEIA CAPITAL, L.L.C. removed 219,997 shares (-40.6%) from their portfolio in Q1 2025, for an estimated $46,412,767
- GAMMA INVESTING LLC removed 217,846 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $56,367,652
- MILLENNIUM MANAGEMENT LLC removed 180,514 shares (-45.8%) from their portfolio in Q1 2025, for an estimated $38,083,038
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$20,000 of URBAN ONE INC. (FORMERLY KNOWN AS RADIO ONE INC.) lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Monitor issues related to radio broadcasting."
You can find more data on corporate lobbying on Quiver Quantitative.
UONEK Hedge Fund Activity
We have seen 13 institutional investors add shares of UONEK stock to their portfolio, and 15 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BOUNDARY CREEK ADVISORS LP removed 586,864 shares (-67.9%) from their portfolio in Q1 2025, for an estimated $422,542
- ZAZOVE ASSOCIATES LLC added 543,798 shares (+13.1%) to their portfolio in Q1 2025, for an estimated $391,534
- BARCLAYS PLC added 94,006 shares (+12.4%) to their portfolio in Q1 2025, for an estimated $67,684
- DIMENSIONAL FUND ADVISORS LP removed 78,302 shares (-10.2%) from their portfolio in Q1 2025, for an estimated $56,377
- MILLENNIUM MANAGEMENT LLC removed 32,237 shares (-21.7%) from their portfolio in Q1 2025, for an estimated $23,210
- XTX TOPCO LTD added 16,361 shares (+inf%) to their portfolio in Q1 2025, for an estimated $11,779
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 14,161 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $10,195
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$40,000 of KALLNER & ASSOCIATES ON BEHALF OF WORTHINGTON INDUSTRIES lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"transportation issues foreign trade issues lobbying on trade and transportation policy lobbying on trade and transportation policy tariff issues"
You can find more data on corporate lobbying on Quiver Quantitative.
WOR Hedge Fund Activity
We have seen 139 institutional investors add shares of WOR stock to their portfolio, and 97 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 1,770,924 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $88,705,583
- BLACKROCK, INC. removed 468,641 shares (-8.8%) from their portfolio in Q1 2025, for an estimated $23,474,227
- FMR LLC added 304,860 shares (+11341.5%) to their portfolio in Q1 2025, for an estimated $15,270,437
- AMERIPRISE FINANCIAL INC added 278,300 shares (+374.1%) to their portfolio in Q1 2025, for an estimated $13,940,047
- CAPITAL INTERNATIONAL INVESTORS removed 269,462 shares (-37.1%) from their portfolio in Q1 2025, for an estimated $13,497,351
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 234,960 shares (+inf%) to their portfolio in Q1 2025, for an estimated $11,769,146
- JANE STREET GROUP, LLC added 202,354 shares (+625.0%) to their portfolio in Q1 2025, for an estimated $10,135,911
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
WOR Analyst Ratings
Wall Street analysts have issued reports on $WOR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Sell" rating on 06/26/2025
- Canaccord Genuity issued a "Buy" rating on 06/26/2025
- Seaport Global issued a "Buy" rating on 04/03/2025
To track analyst ratings and price targets for WOR, check out Quiver Quantitative's $WOR forecast page.
WOR Price Targets
Multiple analysts have issued price targets for $WOR recently. We have seen 3 analysts offer price targets for $WOR in the last 6 months, with a median target of $60.0.
Here are some recent targets:
- Susan Maklari from Goldman Sachs set a target price of $50.0 on 06/26/2025
- Brian McNamara from Canaccord Genuity set a target price of $81.0 on 06/26/2025
- Martin Englert from Seaport Global set a target price of $60.0 on 04/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$60,000 of COMPASS PATHWAYS INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines."
You can find more data on corporate lobbying on Quiver Quantitative.
CMPS Hedge Fund Activity
We have seen 60 institutional investors add shares of CMPS stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEEP TRACK CAPITAL, LP added 8,859,648 shares (+inf%) to their portfolio in Q1 2025, for an estimated $25,338,593
- RTW INVESTMENTS, LP added 2,439,181 shares (+78.7%) to their portfolio in Q1 2025, for an estimated $6,976,057
- LOGOS GLOBAL MANAGEMENT LP added 2,000,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $5,720,000
- NANTAHALA CAPITAL MANAGEMENT, LLC added 1,829,232 shares (+182.9%) to their portfolio in Q1 2025, for an estimated $5,231,603
- VIVO CAPITAL, LLC added 1,754,385 shares (+109.1%) to their portfolio in Q1 2025, for an estimated $5,017,541
- ALTIUM CAPITAL MANAGEMENT LLC removed 1,424,400 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $4,073,784
- LAURION CAPITAL MANAGEMENT LP added 1,325,595 shares (+301.7%) to their portfolio in Q1 2025, for an estimated $3,791,201
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CMPS Analyst Ratings
Wall Street analysts have issued reports on $CMPS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 07/15/2025
- Cantor Fitzgerald issued a "Overweight" rating on 05/27/2025
- Canaccord Genuity issued a "Buy" rating on 02/28/2025
- Stifel issued a "Buy" rating on 02/27/2025
To track analyst ratings and price targets for CMPS, check out Quiver Quantitative's $CMPS forecast page.
CMPS Price Targets
Multiple analysts have issued price targets for $CMPS recently. We have seen 5 analysts offer price targets for $CMPS in the last 6 months, with a median target of $12.0.
Here are some recent targets:
- Patrick Trucchio from HC Wainwright & Co. set a target price of $45.0 on 07/15/2025
- Josh Schimmer from Evercore ISI Group set a target price of $6.0 on 06/23/2025
- Josh Schimmer from Cantor Fitzgerald set a target price of $12.0 on 05/27/2025
- Sumant Kulkarni from Canaccord Genuity set a target price of $15.0 on 02/28/2025
- Paul Matteis from Stifel set a target price of $11.0 on 02/27/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$220,000 of THE MOSAIC COMPANY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Rare earth elements phosphogypsum reuse ; S1014 / H.R. 2030: Maintaining Cooperative Permitting Act of 2025; HR 3898 The PERMIT Act phosphogypsum reuse Biologicals/plant biostimulants"
You can find more data on corporate lobbying on Quiver Quantitative.
MOS Insider Trading Activity
MOS insiders have traded $MOS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MOS stock by insiders over the last 6 months:
- BRUCE M. BODINE (President and CEO) sold 180,708 shares for an estimated $5,703,144
- WALTER F. III PRECOURT (SVP - Chief Admin Officer) sold 18,000 shares for an estimated $643,140
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MOS Hedge Fund Activity
We have seen 331 institutional investors add shares of MOS stock to their portfolio, and 324 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 5,375,239 shares (-18.7%) from their portfolio in Q1 2025, for an estimated $145,185,205
- FMR LLC added 4,358,180 shares (+2281.0%) to their portfolio in Q1 2025, for an estimated $117,714,441
- CAPITAL WORLD INVESTORS removed 3,456,196 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $93,351,853
- POINT72 ASSET MANAGEMENT, L.P. added 2,618,983 shares (+167.8%) to their portfolio in Q1 2025, for an estimated $70,738,730
- AUSTRALIANSUPER PTY LTD removed 2,432,854 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $65,711,386
- BOSTON PARTNERS added 2,368,094 shares (+42.2%) to their portfolio in Q1 2025, for an estimated $63,962,218
- FULLER & THALER ASSET MANAGEMENT, INC. added 2,034,527 shares (+inf%) to their portfolio in Q1 2025, for an estimated $54,952,574
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MOS Analyst Ratings
Wall Street analysts have issued reports on $MOS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 05/14/2025
- Scotiabank issued a "Sector Outperform" rating on 05/14/2025
- Oppenheimer issued a "Outperform" rating on 05/13/2025
- JP Morgan issued a "Overweight" rating on 05/09/2025
- RBC Capital issued a "Outperform" rating on 05/08/2025
- Goldman Sachs issued a "Buy" rating on 03/13/2025
To track analyst ratings and price targets for MOS, check out Quiver Quantitative's $MOS forecast page.
MOS Price Targets
Multiple analysts have issued price targets for $MOS recently. We have seen 11 analysts offer price targets for $MOS in the last 6 months, with a median target of $35.0.
Here are some recent targets:
- Richard Garchitorena from Wells Fargo set a target price of $38.0 on 07/17/2025
- Kristen Owen from Oppenheimer set a target price of $43.0 on 07/15/2025
- Benjamin Theurer from Barclays set a target price of $46.0 on 07/07/2025
- Ben Isaacson from Scotiabank set a target price of $42.0 on 05/14/2025
- Hamir Patel from CIBC set a target price of $33.0 on 05/09/2025
- Jeffrey Zekaukas from JP Morgan set a target price of $35.0 on 05/09/2025
- Andrew Wong from RBC Capital set a target price of $40.0 on 05/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$80,000 of CONAGRA BRANDS INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to FDA's Generally Recognized as Safe (GRAS) regulations; Issues related to state food additive bans and labeling laws; Issues related to the labeling of plant-based foods; Issues related to recyclability labeling; Issues related to purchasing restrictions within the Supplemental Nutrition Assistance Program; Issues stemming from Executive Order Establishing the Presidents Make America Healthy Again Commission. Tariff issues related to Executive Orders 14226, 14227, 14257, 14259, 14266"
You can find more data on corporate lobbying on Quiver Quantitative.
CAG Congressional Stock Trading
Members of Congress have traded $CAG stock 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CAG stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/30.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/08, 02/25.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CAG Hedge Fund Activity
We have seen 387 institutional investors add shares of CAG stock to their portfolio, and 391 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 12,682,793 shares (-99.8%) from their portfolio in Q1 2025, for an estimated $338,250,089
- ILEX CAPITAL PARTNERS (UK) LLP removed 4,289,918 shares (-86.1%) from their portfolio in Q1 2025, for an estimated $114,412,113
- AMERIPRISE FINANCIAL INC added 4,191,555 shares (+233.7%) to their portfolio in Q1 2025, for an estimated $111,788,771
- CITADEL ADVISORS LLC added 3,670,033 shares (+170.8%) to their portfolio in Q1 2025, for an estimated $97,879,780
- ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. added 3,128,203 shares (+315.4%) to their portfolio in Q2 2025, for an estimated $64,034,315
- DIMENSIONAL FUND ADVISORS LP added 2,702,407 shares (+49.5%) to their portfolio in Q1 2025, for an estimated $72,073,194
- AMERICAN CENTURY COMPANIES INC removed 2,656,493 shares (-27.7%) from their portfolio in Q1 2025, for an estimated $70,848,668
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CAG Analyst Ratings
Wall Street analysts have issued reports on $CAG in the last several months. We have seen 1 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Underperform" rating on 06/12/2025
- Goldman Sachs issued a "Sell" rating on 06/09/2025
- Barclays issued a "Overweight" rating on 05/12/2025
To track analyst ratings and price targets for CAG, check out Quiver Quantitative's $CAG forecast page.
CAG Price Targets
Multiple analysts have issued price targets for $CAG recently. We have seen 10 analysts offer price targets for $CAG in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Bryan Adams from UBS set a target price of $20.0 on 07/11/2025
- Nik Modi from RBC Capital set a target price of $22.0 on 07/11/2025
- Chris Carey from Wells Fargo set a target price of $20.0 on 07/11/2025
- David Palmer from Evercore ISI Group set a target price of $24.0 on 07/11/2025
- Megan Alexander from Morgan Stanley set a target price of $20.0 on 07/11/2025
- Matthew Smith from Stifel set a target price of $21.0 on 07/11/2025
- Bryan Spillane from B of A Securities set a target price of $20.0 on 06/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$140,000 of DALRADIAN USA lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Inform policymakers of US direct investment in Northern Ireland. No specific legislation."
You can find more data on corporate lobbying on Quiver Quantitative.
GNSS Hedge Fund Activity
We have seen 31 institutional investors add shares of GNSS stock to their portfolio, and 21 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ROYCE & ASSOCIATES LP removed 520,252 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $1,180,972
- INTEGRITY WEALTH ADVISORS, INC. added 322,373 shares (+4.8%) to their portfolio in Q1 2025, for an estimated $731,786
- MARSHALL WACE, LLP added 297,433 shares (+862.6%) to their portfolio in Q1 2025, for an estimated $675,172
- EVERNEST FINANCIAL ADVISORS, LLC added 294,267 shares (+1548.8%) to their portfolio in Q1 2025, for an estimated $667,986
- FI3 FINANCIAL ADVISORS, LLC added 290,346 shares (+inf%) to their portfolio in Q1 2025, for an estimated $659,085
- FNY INVESTMENT ADVISERS, LLC added 238,114 shares (+87.5%) to their portfolio in Q1 2025, for an estimated $540,518
- MARINER, LLC added 135,239 shares (+inf%) to their portfolio in Q1 2025, for an estimated $306,992
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GNSS Analyst Ratings
Wall Street analysts have issued reports on $GNSS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Ascendiant Capital issued a "Buy" rating on 06/06/2025
To track analyst ratings and price targets for GNSS, check out Quiver Quantitative's $GNSS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$80,000 of BABCOCK & WILCOX ENTERPRISES INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Implementation of the Consolidated Appropriations Act, 2023 (H.R.2617 - P.L. 117-328). Issues related to Chemical Looping Processes. Issues related to Department of Energy funding deployment. H.R.4366 - Consolidated Appropriations Act, 2024 (P.L. 118-42). Fiscal Year 2025Appropriations. Issues related to chemical looping provisions for Fiscal Year 2026 government funding legislation. Fiscal Year 2026 Energy and Water Appropriations language. Issues related to implementation of the Inflation Reduction Act P.L. 117-169. Issues related to the implementation of Department of Energy funding programs and awards. Issues related to energy infrastructure, carbon capture technologies, and clean energy standards. Issues related to hydrogen. Implementation of the Inflation Reduction Act (P.L. 117-169). Implementation of the Consolidated Appropriations Act, 2023 (H.R.2617 - P.L. 117-328). Issues related to Fiscal Year 2024 Appropriations. Issues related to Department of Energy funding deployment. H.R.4366 - Consolidated Appropriations Act, 2024(P.L. 118-42). Implementation of the Infrastructure Investments and Jobs Act (P.L 117-58). Issues related to chemical looping provisions for Fiscal Year 2026 government funding legislation. One Big Beautiful Bill Act (P.L. 119-21)."
You can find more data on corporate lobbying on Quiver Quantitative.
BW Hedge Fund Activity
We have seen 29 institutional investors add shares of BW stock to their portfolio, and 62 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CASTLEKNIGHT MANAGEMENT LP added 549,170 shares (+7.6%) to their portfolio in Q1 2025, for an estimated $369,261
- GENDELL JEFFREY L added 503,100 shares (+41.2%) to their portfolio in Q1 2025, for an estimated $338,284
- SCOGGIN MANAGEMENT LP removed 500,000 shares (-50.0%) from their portfolio in Q1 2025, for an estimated $336,200
- 683 CAPITAL MANAGEMENT, LLC removed 406,923 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $273,615
- CITADEL ADVISORS LLC removed 403,505 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $271,316
- JPMORGAN CHASE & CO added 402,299 shares (+99.4%) to their portfolio in Q1 2025, for an estimated $270,505
- JANE STREET GROUP, LLC removed 343,648 shares (-83.0%) from their portfolio in Q1 2025, for an estimated $231,068
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BW Analyst Ratings
Wall Street analysts have issued reports on $BW in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Lake Street issued a "Buy" rating on 04/01/2025
To track analyst ratings and price targets for BW, check out Quiver Quantitative's $BW forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$60,000 of UNIVERSAL TECHNICAL INSTITUTE lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Job training; federal education funding."
You can find more data on corporate lobbying on Quiver Quantitative.
UTI Insider Trading Activity
UTI insiders have traded $UTI stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $UTI stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, LLC COLISEUM has made 0 purchases and 4 sales selling 4,134,369 shares for an estimated $126,304,273.
- SHERRELL SMITH (EVP, Chief Academic Officer) has made 0 purchases and 10 sales selling 106,773 shares for an estimated $2,910,733.
- JEROME ALAN GRANT (Chief Executive Officer) sold 56,492 shares for an estimated $1,909,429
- CHRISTOPHER E. KEVANE (EVP and Chief Legal Officer) has made 0 purchases and 2 sales selling 29,400 shares for an estimated $1,003,260.
- TODD A HITCHCOCK (EVP/COO) has made 0 purchases and 2 sales selling 27,500 shares for an estimated $917,470.
- GEORGE W. BROCHICK has made 0 purchases and 2 sales selling 14,000 shares for an estimated $411,799.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
UTI Hedge Fund Activity
We have seen 125 institutional investors add shares of UTI stock to their portfolio, and 95 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WASATCH ADVISORS LP added 2,248,338 shares (+inf%) to their portfolio in Q1 2025, for an estimated $57,737,319
- CONGRESS ASSET MANAGEMENT CO added 1,866,779 shares (+inf%) to their portfolio in Q2 2025, for an estimated $63,265,140
- COLISEUM CAPITAL MANAGEMENT, LLC removed 1,704,881 shares (-24.9%) from their portfolio in Q1 2025, for an estimated $43,781,344
- DUMAC, INC. removed 1,681,681 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $43,185,568
- LORD, ABBETT & CO. LLC added 1,077,076 shares (+58.3%) to their portfolio in Q1 2025, for an estimated $27,659,311
- HOOD RIVER CAPITAL MANAGEMENT LLC added 1,021,592 shares (+inf%) to their portfolio in Q1 2025, for an estimated $26,234,482
- DRIEHAUS CAPITAL MANAGEMENT LLC added 803,402 shares (+inf%) to their portfolio in Q1 2025, for an estimated $20,631,363
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UTI Analyst Ratings
Wall Street analysts have issued reports on $UTI in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 06/12/2025
- Truist Securities issued a "Buy" rating on 05/22/2025
- Lake Street issued a "Buy" rating on 05/21/2025
- Rosenblatt issued a "Buy" rating on 05/08/2025
- Northland Capital Markets issued a "Outperform" rating on 02/06/2025
To track analyst ratings and price targets for UTI, check out Quiver Quantitative's $UTI forecast page.
UTI Price Targets
Multiple analysts have issued price targets for $UTI recently. We have seen 5 analysts offer price targets for $UTI in the last 6 months, with a median target of $36.0.
Here are some recent targets:
- Alexander Paris from Barrington Research set a target price of $36.0 on 06/12/2025
- Jasper Bibb from Truist Securities set a target price of $40.0 on 05/22/2025
- Eric Martinuzzi from Lake Street set a target price of $38.0 on 05/21/2025
- Steve Frankel from Rosenblatt set a target price of $36.0 on 05/08/2025
- Mike Grondahl from Northland Capital Markets set a target price of $34.0 on 02/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$60,000 of SOLVENTUM lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"General issue monitoring related to trade and tariff policy. General issue monitoring related to medical, dental, and health information systems research and development. General issue monitoring related to healthcare policy. H.R.1 - One Big Beautiful Bill Act Issues related to healthcare in the FY26 Appropriations process. General issue monitoring related to Medicare and Medicaid policy. H.R.1 - One Big Beautiful Bill Act General issue monitoring related to medical, dental, and health information systems research and development."
You can find more data on corporate lobbying on Quiver Quantitative.
SOLV Congressional Stock Trading
Members of Congress have traded $SOLV stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $SOLV stock by members of Congress over the last 6 months:
- SENATOR RON WYDEN sold up to $15,000 on 02/06.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
SOLV Hedge Fund Activity
We have seen 278 institutional investors add shares of SOLV stock to their portfolio, and 469 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INDEPENDENT FRANCHISE PARTNERS LLP added 4,217,570 shares (+263.1%) to their portfolio in Q1 2025, for an estimated $320,704,022
- BOSTON PARTNERS added 1,691,565 shares (+101.3%) to their portfolio in Q1 2025, for an estimated $128,626,602
- NUANCE INVESTMENTS, LLC removed 655,847 shares (-48.4%) from their portfolio in Q1 2025, for an estimated $49,870,605
- FMR LLC added 465,460 shares (+44.2%) to their portfolio in Q1 2025, for an estimated $35,393,578
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 432,309 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $32,872,776
- D. E. SHAW & CO., INC. added 413,410 shares (+350.4%) to their portfolio in Q1 2025, for an estimated $31,435,696
- BAUPOST GROUP LLC/MA removed 393,060 shares (-27.2%) from their portfolio in Q1 2025, for an estimated $29,888,282
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SOLV Analyst Ratings
Wall Street analysts have issued reports on $SOLV in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 07/15/2025
- Argus Research issued a "Buy" rating on 07/01/2025
- Piper Sandler issued a "Overweight" rating on 05/19/2025
- Goldman Sachs issued a "Sell" rating on 03/03/2025
To track analyst ratings and price targets for SOLV, check out Quiver Quantitative's $SOLV forecast page.
SOLV Price Targets
Multiple analysts have issued price targets for $SOLV recently. We have seen 6 analysts offer price targets for $SOLV in the last 6 months, with a median target of $83.5.
Here are some recent targets:
- Patrick Wood from Morgan Stanley set a target price of $103.0 on 07/15/2025
- Jason Bednar from Piper Sandler set a target price of $87.0 on 05/19/2025
- Steven Valiquette from Mizuho set a target price of $82.0 on 03/03/2025
- David Roman from Goldman Sachs set a target price of $71.0 on 03/03/2025
- Vik Chopra from Wells Fargo set a target price of $75.0 on 02/28/2025
- Travis Steed from B of A Securities set a target price of $85.0 on 02/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of CHESS CLUB AND SCHOLASTIC CENTER OF SAINT LOUIS lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Chess education and funding issues."
You can find more data on corporate lobbying on Quiver Quantitative.
SCHL Hedge Fund Activity
We have seen 84 institutional investors add shares of SCHL stock to their portfolio, and 71 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ANANYM CAPITAL MANAGEMENT, LP added 1,250,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $23,600,000
- PACER ADVISORS, INC. removed 838,366 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $15,828,350
- VANGUARD GROUP INC removed 600,434 shares (-22.8%) from their portfolio in Q1 2025, for an estimated $11,336,193
- JONES FINANCIAL COMPANIES LLLP added 518,351 shares (+245664.0%) to their portfolio in Q1 2025, for an estimated $9,786,466
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 260,830 shares (-80.7%) from their portfolio in Q1 2025, for an estimated $4,924,470
- ACADIAN ASSET MANAGEMENT LLC removed 246,747 shares (-83.8%) from their portfolio in Q1 2025, for an estimated $4,658,583
- UBS GROUP AG removed 234,139 shares (-53.4%) from their portfolio in Q1 2025, for an estimated $4,420,544
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of LAS VEGAS SANDS CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Monitor federal legislative and regulatory policy issues related to internet gambling. Monitor legislative efforts related to hospitality, convention, trade show and travel industries. Monitor issues related to Tax Cuts and Jobs Act (TCJA) P.L. 115-97. Monitor issues related to US-China relations. Monitor issues related to international business and travel, and tourism."
You can find more data on corporate lobbying on Quiver Quantitative.
LVS Congressional Stock Trading
Members of Congress have traded $LVS stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $LVS stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
LVS Insider Trading Activity
LVS insiders have traded $LVS stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LVS stock by insiders over the last 6 months:
- MUKTESH PANT purchased 23,000 shares for an estimated $1,000,730
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LVS Hedge Fund Activity
We have seen 316 institutional investors add shares of LVS stock to their portfolio, and 323 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 31,592,047 shares (-53.7%) from their portfolio in Q1 2025, for an estimated $1,220,400,775
- FISHER ASSET MANAGEMENT, LLC removed 13,743,368 shares (-99.5%) from their portfolio in Q1 2025, for an estimated $530,906,305
- JANUS HENDERSON GROUP PLC removed 6,382,458 shares (-44.9%) from their portfolio in Q1 2025, for an estimated $246,554,352
- CITADEL ADVISORS LLC added 4,578,100 shares (+456.6%) to their portfolio in Q1 2025, for an estimated $176,852,003
- JANE STREET GROUP, LLC added 3,718,116 shares (+61.3%) to their portfolio in Q1 2025, for an estimated $143,630,821
- BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 3,204,897 shares (-34.2%) from their portfolio in Q1 2025, for an estimated $123,805,171
- VANGUARD GROUP INC added 2,267,307 shares (+5.8%) to their portfolio in Q1 2025, for an estimated $87,586,069
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LVS Analyst Ratings
Wall Street analysts have issued reports on $LVS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Susquehanna issued a "Positive" rating on 07/21/2025
- Barclays issued a "Overweight" rating on 07/18/2025
- Macquarie issued a "Outperform" rating on 04/24/2025
- Stifel issued a "Buy" rating on 04/24/2025
- Citigroup issued a "Buy" rating on 01/30/2025
- Wells Fargo issued a "Overweight" rating on 01/30/2025
To track analyst ratings and price targets for LVS, check out Quiver Quantitative's $LVS forecast page.
LVS Price Targets
Multiple analysts have issued price targets for $LVS recently. We have seen 10 analysts offer price targets for $LVS in the last 6 months, with a median target of $54.5.
Here are some recent targets:
- Joseph Stauff from Susquehanna set a target price of $58.0 on 07/21/2025
- Brandt Montour from Barclays set a target price of $57.0 on 07/18/2025
- Stephen Grambling from Morgan Stanley set a target price of $47.0 on 07/11/2025
- Robin Farley from UBS set a target price of $48.0 on 07/08/2025
- Lizzie Dove from Goldman Sachs set a target price of $52.0 on 07/07/2025
- Daniel Politzer from JP Morgan set a target price of $47.0 on 06/23/2025
- Chad Beynon from Macquarie set a target price of $52.0 on 04/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$60,000 of WHIRLPOOL CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"General trade issues."
You can find more data on corporate lobbying on Quiver Quantitative.
POOL Insider Trading Activity
POOL insiders have traded $POOL stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $POOL stock by insiders over the last 6 months:
- DE LA MESA MANUEL J PEREZ has made 0 purchases and 4 sales selling 37,500 shares for an estimated $13,041,250.
- HART MELANIE HOUSEY (Senior VP CFO and Treasurer) has made 0 purchases and 2 sales selling 2,312 shares for an estimated $799,005.
- JENNIFER M NEIL (Sr VP, Sec & Chief Legal Off) sold 1,223 shares for an estimated $385,245
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
POOL Hedge Fund Activity
We have seen 323 institutional investors add shares of POOL stock to their portfolio, and 369 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BERKSHIRE HATHAWAY INC added 865,311 shares (+144.5%) to their portfolio in Q1 2025, for an estimated $275,471,756
- MAWER INVESTMENT MANAGEMENT LTD. added 530,029 shares (+inf%) to their portfolio in Q1 2025, for an estimated $168,734,732
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 455,163 shares (+inf%) to their portfolio in Q1 2025, for an estimated $144,901,141
- GAMMA INVESTING LLC removed 259,065 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $75,512,266
- BLAIR WILLIAM & CO/IL removed 190,741 shares (-26.9%) from their portfolio in Q1 2025, for an estimated $60,722,397
- PICTET ASSET MANAGEMENT HOLDING SA added 160,420 shares (+25.2%) to their portfolio in Q1 2025, for an estimated $51,069,707
- MORGAN STANLEY added 158,272 shares (+16.2%) to their portfolio in Q1 2025, for an estimated $50,385,891
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
POOL Analyst Ratings
Wall Street analysts have issued reports on $POOL in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stephens & Co. issued a "Overweight" rating on 04/28/2025
- Oppenheimer issued a "Outperform" rating on 04/28/2025
To track analyst ratings and price targets for POOL, check out Quiver Quantitative's $POOL forecast page.
POOL Price Targets
Multiple analysts have issued price targets for $POOL recently. We have seen 6 analysts offer price targets for $POOL in the last 6 months, with a median target of $326.0.
Here are some recent targets:
- Sam Reid from Wells Fargo set a target price of $320.0 on 07/08/2025
- Scott Schneeberger from Oppenheimer set a target price of $322.0 on 04/28/2025
- Trey Grooms from Stephens & Co. set a target price of $350.0 on 04/28/2025
- David Manthey from Baird set a target price of $310.0 on 04/25/2025
- W. Andrew Carter from Stifel set a target price of $330.0 on 04/23/2025
- Collin Verron from Deutsche Bank set a target price of $344.0 on 04/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$230,000 of STRYKER CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Stroke pathways Medicare extenders for EMS Issues related to global supply chains for medical devices Issues related to global supply chains Issues related to reprocessing Issues related to PPE Issues related to prevention of hospital-acquired pneumonia Issues related to rural EMS programs Issues related to digital health Issues related to smoke evacuation in the OR Issues related to employment, training and workplace safety Issues related to tax reform Issues related to school safety"
You can find more data on corporate lobbying on Quiver Quantitative.
SYK Congressional Stock Trading
Members of Congress have traded $SYK stock 9 times in the past 6 months. Of those trades, 2 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $SYK stock by members of Congress over the last 6 months:
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 06/26, 02/26.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 04/17 and 2 sales worth up to $200,000 on 05/12, 03/13.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/08.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
SYK Insider Trading Activity
SYK insiders have traded $SYK stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $SYK stock by insiders over the last 6 months:
- RONDA E STRYKER has made 0 purchases and 12 sales selling 401,392 shares for an estimated $154,384,916.
- ALLAN C. GOLSTON sold 2,458 shares for an estimated $941,586
- WILLIAM E JR BERRY (VP, Chief Accounting Officer) sold 1,241 shares for an estimated $482,202
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SYK Hedge Fund Activity
We have seen 1,059 institutional investors add shares of SYK stock to their portfolio, and 850 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 2,069,311 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $818,681,510
- WELLINGTON MANAGEMENT GROUP LLP removed 1,981,824 shares (-23.7%) from their portfolio in Q1 2025, for an estimated $737,733,984
- JPMORGAN CHASE & CO added 1,808,077 shares (+16.7%) to their portfolio in Q1 2025, for an estimated $673,056,663
- BANK OF AMERICA CORP /DE/ added 1,040,407 shares (+35.0%) to their portfolio in Q1 2025, for an estimated $387,291,505
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,021,496 shares (+9.2%) to their portfolio in Q1 2025, for an estimated $380,251,886
- PROFICIO CAPITAL PARTNERS LLC removed 594,363 shares (-99.7%) from their portfolio in Q1 2025, for an estimated $221,251,626
- MORGAN STANLEY added 559,172 shares (+10.1%) to their portfolio in Q1 2025, for an estimated $208,151,777
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SYK Analyst Ratings
Wall Street analysts have issued reports on $SYK in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 05/22/2025
- Evercore ISI Group issued a "Outperform" rating on 05/02/2025
- Roth MKM issued a "Buy" rating on 05/02/2025
- Needham issued a "Buy" rating on 03/21/2025
- Barclays issued a "Overweight" rating on 02/10/2025
- Stifel issued a "Buy" rating on 01/29/2025
- Canaccord Genuity issued a "Buy" rating on 01/29/2025
To track analyst ratings and price targets for SYK, check out Quiver Quantitative's $SYK forecast page.
SYK Price Targets
Multiple analysts have issued price targets for $SYK recently. We have seen 12 analysts offer price targets for $SYK in the last 6 months, with a median target of $437.5.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $415.0 on 07/08/2025
- Joanne Wuensch from Citigroup set a target price of $455.0 on 05/22/2025
- Richard Newitter from Truist Securities set a target price of $400.0 on 05/05/2025
- Jason Wittes from Roth MKM set a target price of $456.0 on 05/02/2025
- Mike Matson from Needham set a target price of $442.0 on 03/21/2025
- Matt Miksic from Barclays set a target price of $443.0 on 02/10/2025
- David Roman from Goldman Sachs set a target price of $427.0 on 01/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$50,000 of PELOTON INTERACTIVE INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Lobbying in support of legislation allowing American taxpayers a medical care tax deduction for up to $1,000 ($2,000 for a joint return or a head of household) of qualified sports and fitness expenses per year. This bill was recently re-introduced as The PHIT Act, S. 786, HR 1582, and had elements included in HR 1 the One Big Beautiful Bill. Lobbying in support of legislation allowing American taxpayers a medical care tax deduction for up to $1,000 ($2,000 for a joint return or a head of household) of qualified sports and fitness expenses per year. This bill was recently re-introduced as The PHIT Act, S. 786, HR 1582, and had elements within HR1 the One Big Beautiful Bill. Lobbying in support of renewing Section 174's domestic R&D tax deduction and return to EBITDA accounting standard vs. EBIT in HR 1 the One Big Beautiful Bill. General interest in new global reciprocal tariffs and expansions to Section 232 steel, aluminum, electronics and critical minerals tariffs. General interest in new global reciprocal tariffs and expansions to Section 232 steel, aluminum, electronics, and critical minerals tariffs. Lobbying in support of legislation allowing American taxpayers a medical care tax deduction for up to $1,000 ($2,000 for a joint return or a head of household) of qualified sports and fitness expenses per year. This bill was recently re-introduced as The PHIT Act, S. 786, HR 1582, and had elements included in the HR 1 One Big Beautiful Bill. Lobbying generally in support of programs to support the inclusion of fitness and mental health programming as part of broader nationwide healthcare policies."
You can find more data on corporate lobbying on Quiver Quantitative.
PTON Insider Trading Activity
PTON insiders have traded $PTON stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $PTON stock by insiders over the last 6 months:
- JENNIFER CUNNINGHAM COTTER (Chief Content Officer) has made 0 purchases and 5 sales selling 647,104 shares for an estimated $4,698,695.
- ELIZABETH F CODDINGTON (Chief Financial Officer) has made 0 purchases and 6 sales selling 433,339 shares for an estimated $3,341,321.
- ANDREW S RENDICH (Chief Supply Chain Officer) has made 0 purchases and 3 sales selling 163,498 shares for an estimated $1,526,078.
- NICK V. CALDWELL (Chief Product Officer) has made 0 purchases and 4 sales selling 230,701 shares for an estimated $1,521,977.
- DION C. SANDERS (Chief Commercial Officer) has made 0 purchases and 2 sales selling 236,354 shares for an estimated $1,516,333.
- SAQIB BAIG (Chief Accounting Officer) has made 0 purchases and 5 sales selling 91,491 shares for an estimated $739,339.
- CHARLES PETER KIROL (Chief Operating Officer) sold 20,633 shares for an estimated $131,822
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PTON Hedge Fund Activity
We have seen 219 institutional investors add shares of PTON stock to their portfolio, and 192 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 31,637,067 shares (-65.0%) from their portfolio in Q1 2025, for an estimated $199,946,263
- FMR LLC added 14,570,614 shares (+135.4%) to their portfolio in Q1 2025, for an estimated $92,086,280
- DME CAPITAL MANAGEMENT, LP removed 5,519,279 shares (-52.5%) from their portfolio in Q1 2025, for an estimated $34,881,843
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 4,940,422 shares (+29.4%) to their portfolio in Q1 2025, for an estimated $31,223,467
- D. E. SHAW & CO., INC. removed 3,113,559 shares (-16.9%) from their portfolio in Q1 2025, for an estimated $19,677,692
- COOPER CREEK PARTNERS MANAGEMENT LLC added 3,014,473 shares (+inf%) to their portfolio in Q1 2025, for an estimated $19,051,469
- NANTAHALA CAPITAL MANAGEMENT, LLC removed 2,863,111 shares (-39.6%) from their portfolio in Q1 2025, for an estimated $18,094,861
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PTON Analyst Ratings
Wall Street analysts have issued reports on $PTON in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Macquarie issued a "Outperform" rating on 05/13/2025
- Truist Securities issued a "Buy" rating on 04/28/2025
- B of A Securities issued a "Buy" rating on 04/15/2025
- Canaccord Genuity issued a "Buy" rating on 03/14/2025
To track analyst ratings and price targets for PTON, check out Quiver Quantitative's $PTON forecast page.
PTON Price Targets
Multiple analysts have issued price targets for $PTON recently. We have seen 9 analysts offer price targets for $PTON in the last 6 months, with a median target of $9.5.
Here are some recent targets:
- Paul Golding from Macquarie set a target price of $10.0 on 05/13/2025
- Eric Sheridan from Goldman Sachs set a target price of $7.0 on 05/09/2025
- Dana Telsey from Telsey Advisory Group set a target price of $8.0 on 05/09/2025
- Youssef Squali from Truist Securities set a target price of $11.0 on 04/28/2025
- Lauren Schenk from Morgan Stanley set a target price of $4.0 on 04/17/2025
- Curtis Nagle from B of A Securities set a target price of $9.5 on 04/15/2025
- Doug Anmuth from JP Morgan set a target price of $7.0 on 04/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$200,000 of ALLIANT ENERGY CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Departments of Labor, Health and Human Services, and Education, and Related Agencies Act, 2025 FY25 Low Income Home Energy Assistance Program (LIHEAP) funding levels H.R. 1968, Full Year Continuing Appropriations and Extensions Act, 2025 Implementation of H.R.5376, Inflation Reduction Act of 2022 H.R. 1- The One Big Beautiful Bill Act Tax Cuts and Jobs Act issues generally Load growth, reliability, and resource adequacy generally; Energy security issues generally; Issues related to energy grid supply chain; 811 locate services issues generally."
You can find more data on corporate lobbying on Quiver Quantitative.
LNT Hedge Fund Activity
We have seen 381 institutional investors add shares of LNT stock to their portfolio, and 287 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,923,234 shares (-69.8%) from their portfolio in Q1 2025, for an estimated $188,110,107
- CITADEL ADVISORS LLC removed 1,235,886 shares (-99.9%) from their portfolio in Q1 2025, for an estimated $79,529,264
- GAMMA INVESTING LLC removed 1,095,014 shares (-98.3%) from their portfolio in Q2 2025, for an estimated $66,215,496
- THRIVENT FINANCIAL FOR LUTHERANS removed 1,083,138 shares (-46.6%) from their portfolio in Q1 2025, for an estimated $69,699,930
- BLACKROCK, INC. removed 978,766 shares (-4.0%) from their portfolio in Q1 2025, for an estimated $62,983,592
- MAGELLAN ASSET MANAGEMENT LTD removed 915,040 shares (-84.1%) from their portfolio in Q1 2025, for an estimated $58,882,823
- MAIRS & POWER INC removed 869,329 shares (-22.2%) from their portfolio in Q1 2025, for an estimated $55,941,321
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LNT Analyst Ratings
Wall Street analysts have issued reports on $LNT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 05/20/2025
- Barclays issued a "Underweight" rating on 04/22/2025
To track analyst ratings and price targets for LNT, check out Quiver Quantitative's $LNT forecast page.
LNT Price Targets
Multiple analysts have issued price targets for $LNT recently. We have seen 6 analysts offer price targets for $LNT in the last 6 months, with a median target of $65.5.
Here are some recent targets:
- Julien Dumoulin-Smith from UBS set a target price of $67.0 on 07/11/2025
- Steve Fleishman from Wolfe Research set a target price of $68.0 on 07/07/2025
- Julien Dumoulin-Smith from Jefferies set a target price of $71.0 on 05/20/2025
- James Thalacker from BMO Capital set a target price of $64.0 on 04/22/2025
- Nicholas Campanella from Barclays set a target price of $61.0 on 04/22/2025
- Shahriar Pourreza from Guggenheim set a target price of $57.0 on 02/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$810,000 of BLACKROCK FUNDS SERVICES GROUP LLC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Financial Stability Issues Outbound Investment Investment manager passivity requirements Fed/FDIC/OCC long-term debt proposal Regulation O Infrastructure Investment Financial Stability Issues Stewardship Investment manager passivity requirements Exchange Traded Products Sustainability Disclosure Rule 15c2-11 Money Market Fund Reform U.S. Treasury Market Structure Proxy Process Secure 2.0 Digital Assets Equity Market Structure Central Counter Party Risk Swap Block Sizes Uncleared Margin Rules SEC Outsourcing Proposal SEC Open-End Fund Liquidity Risk Management and Swing Pricing Proposal SEC Safeguarding/Custody Rule SEC Predictive Data Analytics Outbound Investment General briefings on compliance with applicable federal law Accredited Investor Status for IRA investments SEC Rule 3b-16, Reg ATS/Definition of Exchange SEC Treasury Clearing Rule SEC Dealer Definition Rule Private Credit Regulation FERC blanket authorization AI Basel III/GSIB Capital Rules CFTC 1.25 Proposal Closed-end funds QPAM Fed/FDIC/OCC long-term debt proposal Common ownership ETF share class Stablecoin legislation Crypto regulation Tokenization Access to private investments Private assets in defined contribution (DC) plans Acquired fund fees and expenses (AFFE) SEC Rule 206(4)-5 E-Delivery legislation DOL fiduciary proposal 403(b) investment parity Secure 2.0 QPAM Child Savings Accounts/ Early Wealth Building/ Trump + MAGA Accounts Access Issues Emergency Savings Accounts Retirement Tax Advantage Private assets in DC plans Social Security Solvency Defined Benefit Plan Solvency Decumulation and Lifetime Income Repeal of 852b6 Accredited Investor Status for IRA investments Taxation of digital assets Proposed Section 899 BEAT (Base Erosion Adjustment Tax) 162m Stock buybacks Endowments Tax Private Foundations Tax Clean Energy Tax Infrastructure Data Management Artificial Intelligence"
You can find more data on corporate lobbying on Quiver Quantitative.
BLK Congressional Stock Trading
Members of Congress have traded $BLK stock 12 times in the past 6 months. Of those trades, 3 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $BLK stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE has traded it 5 times. They made 2 purchases worth up to $200,000 on 04/07, 03/31 and 3 sales worth up to $300,000 on 05/12, 05/08, 02/24.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/09, 04/01.
- REPRESENTATIVE GREG LANDSMAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 03/27, 02/18.
- REPRESENTATIVE TIM MOORE purchased up to $50,000 on 03/04.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 02/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BLK Insider Trading Activity
BLK insiders have traded $BLK stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $BLK stock by insiders over the last 6 months:
- J. RICHARD KUSHEL (Senior Managing Director) has made 0 purchases and 7 sales selling 32,430 shares for an estimated $32,063,608.
- LAURENCE FINK (Chairman and CEO) has made 0 purchases and 11 sales selling 16,485 shares for an estimated $15,119,633.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BLK Hedge Fund Activity
We have seen 20 institutional investors add shares of BLK stock to their portfolio, and 101 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEKABANK DEUTSCHE GIROZENTRALE removed 265,494 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $251,284,761
- BEUTEL, GOODMAN & CO LTD. removed 255,210 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $241,551,160
- DEARBORN PARTNERS LLC removed 34,716 shares (-87.8%) from their portfolio in Q1 2025, for an estimated $32,857,999
- WEALTH ENHANCEMENT ADVISORY SERVICES, LLC removed 32,122 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $30,402,830
- NATIONAL MUTUAL INSURANCE FEDERATION OF AGRICULTURAL COOPERATIVES removed 29,400 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $27,826,512
- NORTHCREST ASSET MANANGEMENT, LLC removed 25,480 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $24,116,310
- DNB ASSET MANAGEMENT AS removed 21,473 shares (-34.4%) from their portfolio in Q1 2025, for an estimated $20,323,765
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BLK Analyst Ratings
Wall Street analysts have issued reports on $BLK in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 07/16/2025
- Barclays issued a "Overweight" rating on 07/14/2025
- Morgan Stanley issued a "Overweight" rating on 07/02/2025
- Goldman Sachs issued a "Buy" rating on 06/27/2025
- Argus Research issued a "Buy" rating on 06/17/2025
- Citigroup issued a "Buy" rating on 04/14/2025
- TD Cowen issued a "Buy" rating on 04/09/2025
To track analyst ratings and price targets for BLK, check out Quiver Quantitative's $BLK forecast page.
BLK Price Targets
Multiple analysts have issued price targets for $BLK recently. We have seen 11 analysts offer price targets for $BLK in the last 6 months, with a median target of $1115.0.
Here are some recent targets:
- Kenneth Worthington from JP Morgan set a target price of $1093.0 on 07/16/2025
- Mike Cyprys from Morgan Stanley set a target price of $1224.0 on 07/16/2025
- Michael Brown from Wells Fargo set a target price of $1170.0 on 07/16/2025
- Craig Siegenthaler from B of A Securities set a target price of $1224.0 on 07/16/2025
- Aidan Hall from Keefe, Bruyette & Woods set a target price of $1215.0 on 07/16/2025
- Benjamin Budish from Barclays set a target price of $1210.0 on 07/14/2025
- Alexander Blostein from Goldman Sachs set a target price of $1115.0 on 06/27/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$770,000 of MCDONALD'S CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to nutrition and food safety. Issues related to corporate, individual, and international tax reform. Issues related to OECD tax proposals. Issues related to franchisees. Issues related to workforce. Issues related to the National Labor Relations Act/National Labor Relations Board. Advocacy around McDonald's Education program. Issues related to workforce access to education. Issues related to policy developments in labor and Franchising. Issues related to food quality. Issues related to pricing. Issues related to ingredients. Monitor the Farm Bill reauthorization process. Monitor discussion of conservation programs. Monitor labor, animal health, and other supply chain-related issues within animal agriculture. Tariff issues affecting supply chain. Issues related to data security and privacy."
You can find more data on corporate lobbying on Quiver Quantitative.
MCD Congressional Stock Trading
Members of Congress have traded $MCD stock 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $MCD stock by members of Congress over the last 6 months:
- REPRESENTATIVE CLEO FIELDS purchased up to $50,000 on 06/25.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 06/20.
- REPRESENTATIVE SCOTT FRANKLIN sold up to $50,000 on 06/16.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $50,000 on 06/02.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 2 purchases worth up to $100,000 on 04/11, 03/05 and 1 sale worth up to $50,000 on 05/12.
- REPRESENTATIVE GEORGE WHITESIDES sold up to $250,000 on 03/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
MCD Insider Trading Activity
MCD insiders have traded $MCD stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $MCD stock by insiders over the last 6 months:
- MANUEL JM STEIJAERT (EVP - President, IOM) has made 0 purchases and 2 sales selling 16,459 shares for an estimated $5,146,757.
- JONATHAN BANNER (EVP - Chief Impact Officer) has made 0 purchases and 2 sales selling 10,700 shares for an estimated $3,284,667.
- CHRISTOPHER J KEMPCZINSKI (Chairman and CEO) sold 10,500 shares for an estimated $3,255,525
- JOSEPH M. ERLINGER (President, McDonald's USA) has made 0 purchases and 6 sales selling 4,995 shares for an estimated $1,524,078.
- EDITH MORGAN FLATLEY (EVP - Global CMO) has made 0 purchases and 2 sales selling 4,200 shares for an estimated $1,262,432.
- MARION K. GROSS (EVP-Chief Supply Chain Officer) sold 1,099 shares for an estimated $334,871
- TIFFANIE L. BOYD (EVP - Chief People Officer) sold 1,000 shares for an estimated $309,270
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MCD Hedge Fund Activity
We have seen 1,478 institutional investors add shares of MCD stock to their portfolio, and 1,530 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GALLAGHER FIDUCIARY ADVISORS, LLC added 4,834,873 shares (+112360.5%) to their portfolio in Q1 2025, for an estimated $1,510,269,279
- JPMORGAN CHASE & CO added 4,783,479 shares (+14.6%) to their portfolio in Q1 2025, for an estimated $1,494,215,335
- GAMMA INVESTING LLC removed 3,483,422 shares (-99.6%) from their portfolio in Q2 2025, for an estimated $1,017,751,405
- WELLINGTON MANAGEMENT GROUP LLP removed 2,164,666 shares (-15.4%) from their portfolio in Q1 2025, for an estimated $676,176,718
- MORGAN STANLEY added 2,071,046 shares (+13.4%) to their portfolio in Q1 2025, for an estimated $646,932,639
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,911,861 shares (-17.9%) from their portfolio in Q1 2025, for an estimated $597,208,020
- BANK OF AMERICA CORP /DE/ added 1,799,765 shares (+13.8%) to their portfolio in Q1 2025, for an estimated $562,192,593
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MCD Analyst Ratings
Wall Street analysts have issued reports on $MCD in the last several months. We have seen 7 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 07/09/2025
- Citigroup issued a "Buy" rating on 07/09/2025
- Keybanc issued a "Overweight" rating on 06/30/2025
- Redburn Atlantic issued a "Sell" rating on 06/10/2025
- BMO Capital issued a "Outperform" rating on 05/05/2025
- Barclays issued a "Overweight" rating on 05/02/2025
- Wedbush issued a "Outperform" rating on 02/11/2025
To track analyst ratings and price targets for MCD, check out Quiver Quantitative's $MCD forecast page.
MCD Price Targets
Multiple analysts have issued price targets for $MCD recently. We have seen 17 analysts offer price targets for $MCD in the last 6 months, with a median target of $325.0.
Here are some recent targets:
- Sara Senatore from B of A Securities set a target price of $322.0 on 07/18/2025
- John Glass from Morgan Stanley set a target price of $326.0 on 07/14/2025
- Christine Cho from Goldman Sachs set a target price of $345.0 on 07/10/2025
- Jake Bartlett from Truist Securities set a target price of $356.0 on 07/09/2025
- Jon Tower from Citigroup set a target price of $365.0 on 07/09/2025
- Eric Gonzalez from Keybanc set a target price of $325.0 on 06/30/2025
- Chris Luyckx from Redburn Atlantic set a target price of $260.0 on 06/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
$2,780,000 of SOUTHERN COMPANY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Budget reconciliation, generally; Energy R&D funding; Low Income Home Energy Assistance Program (LIHEAP) funding; FY2025 Energy and Water Development and Related Agencies Appropriations bills, generally; Issues related to the Department of Government Efficiency, generally; Climate change issues, generally; Environmental regulation, generally (Effluent Limitations Guidelines; Good Neighbor Ozone Transport; CAA Sec. 111 rulemaking) S.J.Res. 4, tankless water heater CRA; H.J.Res. 20, tankless water heater CRA; DOE Distribution Transformer Rule; Grid enhancing technologies, generally; Issues related to FERCs transmission planning and cost allocation rule (Order 1920); Issues related to FERCs regional transmission organizations, generally; Issues related to deregulation, generally; DOE Loan Program Office issues, generally (1706); Issues related to Transmission legislation, generally; Issues related to Grid enhancing technologies, generally; Issues related to Natural gas infrastructure development, generally; Issues related to Energy infrastructure development, generally; Issues related to FERC nominations, generally; Issues related to S.2651, the SITE Act; Issues related to Building American Energy Security Act of 2023; Issues related to regional transmission organizations, generally; Issues related to deregulation generally; Issues related to interconnection, generally; Issues related to DOE Loan Program Office, generally; Issues related to wildfires, generally; H.R. 7624, Advancing Grid-Enhancing Technologies Act of 2024; H.R. 4476, PURPA Modernization Act of 2017; H.R. 1897, ESA Amendments of 2025; S.1449 RESTART Act; Issues related to HR 1, generally; Issues related to NEPA and permitting reform, generally; Issues related to Yucca Mountain used fuel repository; Issues related to used fuel management; Issues related to consent-based siting generally; Issues related to AP1000 technology generally; Issues related to Accident Tolerant Fuel program; Issues related to advanced nuclear technology; Issues related to DOE Advanced Reactor Development Program, generally; Issues related to small modular reactors (SMRs) in general; Issues related to natural gas stoves; Issues related to DOE energy efficiency standards for electric distribution transformers; DOE new nuclear R&D programs, generally; NRC fee issues, generally; Issues related to NRC nominees in general; Issues related to the NRC decision on Subsequent License Renewal; Issues related to Subsequent License Renewal, generally; Issues related to nuclear uprates, generally; Issues related to nuclear fuels; Issues related to HAELU fuel; Issues related to distribution transformers, generally; The ADVANCE Act, P.L. 118-67; None. Climate change issues, generally; Environmental regulation, generally; Clean Water Act, generally; Nationwide Permit Program, generally (Clean Water Act Section 404); NEPA Phase II Proposed Rule and NEPA issues, generally; ESA regulations, generally; Issues related to wildfires, generally; Tax Cuts and Jobs Act issues; generally; Inflation Reduction Act Implementation, generally; One Big Beautiful Bill Acct, generally; None. Drone/UAV issues, generally; None. Middle-mile broadband infrastructure issues, generally; Spectrum issues, generally, including the FCC's 6 GHz spectrum proposal and Cruz-Thune spectrum pipeline bill; Pole attachment issues, generally; None."
You can find more data on corporate lobbying on Quiver Quantitative.
SO Congressional Stock Trading
Members of Congress have traded $SO stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SO stock by members of Congress over the last 6 months:
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 04/03.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
SO Insider Trading Activity
SO insiders have traded $SO stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $SO stock by insiders over the last 6 months:
- KIMBERLY S, GREENE (Chairman, President & CEO, GPC) sold 32,190 shares for an estimated $2,997,532
- CHRISTOPHER C WOMACK (Chairman, President & CEO) has made 0 purchases and 2 sales selling 26,000 shares for an estimated $2,343,172.
- JAMES JEFFREY PEOPLES (Chairman, President & CEO, APC) sold 14,540 shares for an estimated $1,250,440
- CHRISTOPHER CUMMISKEY (EVP) has made 0 purchases and 2 sales selling 13,172 shares for an estimated $1,174,214.
- STAN W CONNALLY (EVP & COO) sold 12,500 shares for an estimated $1,153,000
- MARTIN BERNARD DAVIS (EVP & CIO) sold 1,125 shares for an estimated $100,811
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SO Hedge Fund Activity
We have seen 1,063 institutional investors add shares of SO stock to their portfolio, and 838 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GQG PARTNERS LLC removed 14,751,176 shares (-99.7%) from their portfolio in Q1 2025, for an estimated $1,356,370,633
- JPMORGAN CHASE & CO added 7,777,361 shares (+13.9%) to their portfolio in Q1 2025, for an estimated $715,128,343
- SOROBAN CAPITAL PARTNERS LP added 2,229,510 shares (+inf%) to their portfolio in Q1 2025, for an estimated $205,003,444
- CITADEL ADVISORS LLC added 2,208,783 shares (+974.0%) to their portfolio in Q1 2025, for an estimated $203,097,596
- GAMMA INVESTING LLC removed 1,928,734 shares (-98.7%) from their portfolio in Q2 2025, for an estimated $177,115,643
- BANK OF AMERICA CORP /DE/ added 1,927,867 shares (+26.8%) to their portfolio in Q1 2025, for an estimated $177,267,370
- CAPITAL INTERNATIONAL INVESTORS removed 1,472,917 shares (-5.4%) from their portfolio in Q1 2025, for an estimated $135,434,718
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SO Analyst Ratings
Wall Street analysts have issued reports on $SO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 07/22/2025
- Raymond James issued a "Outperform" rating on 06/13/2025
- Jefferies issued a "Buy" rating on 06/05/2025
- Keybanc issued a "Underweight" rating on 05/14/2025
To track analyst ratings and price targets for SO, check out Quiver Quantitative's $SO forecast page.
SO Price Targets
Multiple analysts have issued price targets for $SO recently. We have seen 12 analysts offer price targets for $SO in the last 6 months, with a median target of $95.5.
Here are some recent targets:
- James Thalacker from BMO Capital set a target price of $102.0 on 07/22/2025
- Nicholas Campanella from Barclays set a target price of $91.0 on 07/16/2025
- Jeremy Tonet from JP Morgan set a target price of $97.0 on 07/15/2025
- Stephen Byrd from Morgan Stanley set a target price of $90.0 on 06/18/2025
- J.R. Weston from Raymond James set a target price of $98.0 on 06/13/2025
- Julien Dumoulin-Smith from Jefferies set a target price of $100.0 on 06/05/2025
- Sophie Karp from Keybanc set a target price of $78.0 on 05/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.